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Abstract

The development of regulatory T (Treg) cells is essential for the maintenance of
immune tolerance and homeostasis. In the thymus, TCR-specificity to self-antigen
appears to be a primary determinant for Treg cell lineage commitment, imprinting both
self and foreign antigens in the peripheral Treg cell population to provide dominant
tolerance. The degree of T cell self-reactivity considered dangerous by the immune
system, thereby requiring thymic education to prevent autoimmunity, is unknown. Here, I
analyzed a panel of TCRs with a broad range of reactivity to ovalbumin (OVA323-339) in
the RIP-mOVA self-antigen model for their ability to induce mechanisms of thymic
tolerance. Thymic Treg cell generation in vivo was directly correlated with reactivity to
OVA-peptide in a broad ~1,000-fold range, and its developmental “niche size” was
unexpectedly dependent on TCR affinity. The threshold for Treg cell differentiation was
almost 100-fold lower than that required for eliciting thymic negative selection and
peripheral T cell responses. Thus, these data suggest that Treg cell differentiation is a
default outcome of self-antigen encounter for CD4+ thymocytes, and that thymic
tolerance mechanisms are tuned to limit the escape of self-reactive effectors without Treg
cell chaperones into the periphery. In addition, in the study of developmental stage of
Treg cells, I demonstrated that differentiation of most Treg cells occurs at immature
CD4SP subset, suggesting that medullary APCs may facilitate maturation of thymocyte
after positive selection for efficient induction of Foxp3. In summary, this study suggest
that Treg cell development is driven by self-antigen encounter of CD4SP cells, and TCR
reactivity for self-antigen plays an instructive role in Treg cell differentiation, thereby
i

thymic tolerance mechanisms prevent autoimmunity by restraining the escape of selfreactive effector T cells into the periphery.
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Chapter 1
Background and Significance

It has become well established that the naturally occurring regulatory subset (Treg)
of CD4+ T cells plays an important role in maintaining immune tolerance [1-3]. This is
clearly illustrated by the observation that mutations in the forkhead transcription factor
Foxp3, important for Treg cell function and development, results in lethal multi-organ
autoimmunity.

In humans, children are afflicted by the IPEX syndrome

(immunodysregulation polyendocrinopathy and enteropathy) [4], whereas the murine
equivalent is termed scurfy [5, 6]. Moreover, the acute depletion of Foxp3+ Treg cell
from normal mice unleashes a rapid diffuse lymphoproliferative syndrome leading to
death within 2 weeks [7, 8]. Treg cells have also been shown to prevent excessive
responses to pathogens, participate in immune surveillance on tumor cells, and control a
balance between host and microbial flora [9-11]. In order to understand how Treg cells
impact on these multiple facets of immunity, it is important to determine how Treg cells
are generated.

Brief history of thymic Treg cell development
In order to recognize a wide variety of pathogens, the adaptive immune system
generates an enormously diverse repertoire of antigen receptors by somatic gene
rearrangement. One consequence of this diversity, however, is that the repertoire includes
receptors that recognize self-antigen with the potential to cause autoimmunity. For T cells,
the immune system utilizes an intricate system of development in a specialized organ, the
thymus, to educate the immature T cell population to self prior to their release into the
1

periphery. One mechanism of education is the elimination of immature self-reactive cells,
a process also known as negative selection [12-14] . However, it has become clear that
this culling is not sufficient to achieve tolerance, and some potentially pathogenic cells
escape into the periphery [15, 16].
The notion that a specialized regulatory T cell population is required to inhibit the
cells that escape negative selection was suggested by the classic thymectomy experiment,
in which T cell dependent autoimmunity occurred if thymectomy occurred at day 3, but
not day 7 [17], resulting from what is now thought to be a delay in thymic Treg cell
export [18, 19]. Follow up studies showed that depletion of the CD25 subset revealed the
autoimmune propensity in CD4 single-positive (SP) thymocytes [20]. Thus, it was
suggested that another important educational function of the thymus is to select
regulatory T (Treg) cells to prevent spontaneous autoimmunity [21].

TCR specificity: Self-reactivity of thymic Treg cells
Since Foxp3+ Treg cells comprise only a small fraction of CD4+ T cells, an
important question is whether there are defining features that determine selection into the
Treg cell subset. Early studies inferred that Treg cells may be reactive to self antigens, as
the presence of an organ was required for the maintenance or generation of peripheral T
cells with the ability to suppress autoimmunity to that tissue [22-24]. Subsequent studies
were more direct. For example, it was observed that superantigen increased the frequency
of Treg cells with the appropriate TCRβ chain, suggesting that TCR stimulation was
involved in thymic Treg cell development [25]. Moreover, TCR transgenic mice on a
Rag-deficient background were not found to contain thymic Treg cells, whereas Rag-
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sufficient mice, able to rearrange endogenous TCRα chains, could generate thymic Treg
cells [20, 26]. These data therefore suggested that only certain TCR specificities could
facilitate thymic Treg cell development.
Studies of TCR and cognate antigen transgenic mice provided direct support for
the hypothesis that self-antigen recognition in the thymus was important for directing
thymic Treg cell selection. For example, hemagglutinin (HA) specific TCR transgenic
cells were selected to become Treg cells only when HA was transgenically expressed in
the thymus [27]. Other TCR transgenic models including ovalbumin (OVA) -specific
DO11.10 yielded similar results [28, 29]. From these data, the notion arose that Treg cell
development occurred in the avidity window for self-antigen between positive and
negative selection [30].
However, subsequent data were conflicted regarding whether intrinsic properties
of TCR, such as self-reactivity, specify Treg lineage commitment. In hen egg lysozyme
(HEL)-specific 3A9 TCR transgenic mice, analyses of the absolute number of Treg cells
revealed no significant increase in Treg cell generation when transgenic TCR was
coexpressed with HEL [31]. Similarly, it was found that the proportion of Treg cells
increased without an increase of the absolute numbers when pigeon cytochrome c (PCC)
- reactive AND TCR encountered varying amount of antigen expressed under the control
of tetracycline-dependent transgene system [32] . This observation suggested that agonist
TCR interaction resulted in deletion, rather than Treg cell selection. However, TCR
specificities induced by alternative TCRα chain usage could induce Treg cells and protect
them from agonist mediated deletion, resulting in an overall increase in the frequency of
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Treg cells with increasing agonist ligands. Thus, not all TCR transgenic studies supported
an agonist model of Treg cell selection.
Analyses of polyclonal TCR repertoire also reached conflicting conclusions. It
was reported that Treg cells utilize a distinct, but overlapping, TCR repertoire from that
of non-Treg cells, in favor of a model in which Treg lineage commitment is instructed by
TCR specificity [33-35]. Moreover, T cells transduced with Treg TCRs often rapidly
expanded after adoptive transfer into either normal or lymphopenic hosts, suggesting that
Treg-derived TCRs confer reactivity to self-antigens in vivo [33, 36]. In contrast, another
study argued that self-reactivity is dispensable for Treg cell selection, based on the
observations that TCR repertoire of Treg and non-Treg cell subset were significantly
overlapped, and hybridoma cells expressing Treg TCRs failed to respond to self-antigens
presented by splenocytes or dendritic cells in vitro [37].
Finally, it was suggested that early thymic developmental events condition
thymocytes for differentiation into Treg cell lineage before TCR rearrangement, implying
that TCR specificity is not a specifying factor for thymic Treg cell induction, although
post-differentiation selection based on antigen-specificity is possible [38]. Thus, there
was considerable controversy regarding the role of TCR specificity in thymic Treg cell
selection.
Data from the past several years, however, have been in favor of TCR-mediated
Treg cell selection. First, TCRs from natural Treg, but not naive, cells, are able to
facilitate thymic Treg cell development in TCR transgenic models [39, 40]. Second,
experimental attenuation of MHC II expression on mTECs resulted in preferential Treg
development, rather than negative selection, in a TCR transgenic model involving an
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Aire-promoter driven antigen [41]. Third, intravenous peptide could stimulate Treg cell
development if given within certain dose ranges [42]. Finally, direct assessment of TCR
activation using a new Nur77-GFP reporter revealed that thymic Treg cells were recently
exposed to enhanced levels of TCR stimulation [43]. Thus, the preponderance of current
evidence, discussed in greater detail below, supports an important role for TCR
specificity in thymic Treg cell differentiation.

TCR transgenic mice with natural Treg TCRs
The aforementioned TCR transgenic studies utilized TCRs that were not known to
be normally found in the natural Treg cell population. It was therefore possible that the
experimental manipulation of expressing the cognate antigen using various promoters
may not mimic natural Treg cell development. Recently, several groups independently
reported their experiences with TCR transgenic mice expressing natural Treg TCRs. One
group isolated the natural Treg TCR from OTII -TCR transgenic cells, and only
observed negative selection after generating the Treg TCR transgenic line [44]. It is
possible that this particular TCR was expressed as a secondary TCR chain at low levels
in OTII cells, and therefore had higher affinity than usual for self antigens leading to
negative selection when expressed in a normal context. Two other groups used TCRs
isolated from polyclonal fixed TCRrepertoires in which the skewing of the TCR to the
Treg cell subset was known [39, 40]. Intriguingly, the frequency of Foxp3+ thymocytes
was surprisingly low in the TCR transgenic mice on a Rag-deficient background, which
would not have been predicted based on previous studies of TCR by cognate antigen
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transgenic mice [27-29]. In fact, the initial interpretation by both groups was that this
observation resulted from an experimental artifact of TCR transgenesis.
Substantial thymic Treg cell development was eventually observed only when the
clonal frequency of the TCR transgenic cells was diminished using either mixed bone
marrow chimeras or intrathymic injection. In other words, the clonal frequency of TCR
transgenic cells was inversely correlated with the frequency of Foxp3 + cells. Moreover,
the number of Treg cells generated reached plateau at high clonal frequency, and was
much smaller than the total number of CD4+CD8– (CD4SP) cells that could be generated
by positive selection. These observations led to the notion that thymocytes with a given
TCR specificity undergo intraclonal competition for a small niche with limited
microenvironmental factor(s) important for thymic Treg cell development. Although the
factors defining the Treg cell selection niche are unclear, the most compelling hypothesis
is that the niche represents a limited amount of antigen for which developing thymocytes
must compete in order to undergo Treg cell differentiation.
It is important to note, however, that the limitations imposed by niche size
resulting in intra-(or inter) clonal competition may be more applicable to experimental
immunology rather than normal T cell development in a fully polyclonal population,
where the clonal frequency is likely to be extremely low–on the order of a few to tens of
cells per antigen specificity [45]. In addition to TCR transgenic mice, restricted TCR
repertoires may be susceptible to niche size issues depending on the extent of the
limitation [35], and may provide an explanation regarding the increased overlap between
Treg and non-Treg cell subsets in some studies [37] compared with others [33] .
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The more physiologic implication from the observation of a small Treg cell
developmental niche, at least based on the natural Treg TCRs reported to date, is that the
antigens that drive thymic Treg cell development are likely to be uncommon and likely
tissue-specific antigens, rather than ubiquitous antigens. Moreover, the size of the niche
varies per TCR, suggesting that some Treg TCR ligands are more abundant than others.
The notion of rare Treg cell-inducing ligands would be consistent with the notion that
Aire-dependent tissue specific antigens presented by medullary thymic epithelial cells
(mTECs) can facilitate thymic Treg cell development [46]. This is also supported by an
observation of preferred Treg cell development compared to deletion in low amount of
antigen expression [47]. Finally, uncommon self-ligands would explain why selfreactivity could not be easily detected by direct hybridoma assays [37], but required
assessment of in vivo proliferation in lymphopenic hosts [33, 36]. Direct proof of this
hypothesis will require isolation of natural Treg TCR ligands, which has not yet been
reported to our knowledge. Thus, the preponderance of current data suggests that thymic
Treg cell selection is driven by TCR encounter with rare self-antigens.

Affinity and avidity
As TCR specificity is a primary determinant for thymic Treg cell selection, an
important question is to understand the parameters of TCR:ligand engagement required
for this process. Initial experiments with TCR transgenic models suggested that a high
affinity TCR interaction is required for thymic Treg cell selection. Comparison of two
HA-specific TCR transgenic lines with 1000 fold differences in sensitivity to HA
revealed that Treg cell development only occurred with the high affinity TCR [27].
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Increasing the amount of antigen, i.e. avidity, could not compensate for the difference in
affinity, as levels of antigen sufficient to induce negative selection were still unable to
generate Foxp3+ cells. A different study of Treg cell differentiation in thymic organ
cultures used altered peptide ligands (APL) with varying affinities to the hemoglobinspecific N3.L2 TCR [48]. They observed that strong and weak agonist, but not antagonist,
peptides could induce Treg cell differentiation. Thus, these data suggest that there may
be an affinity threshold, akin to negative selection [13], for which TCR recognition of
agonist ligands is required for thymic Treg cell differentiation.
The role of the avidity in Treg cell differentiation has been also addressed using
transgenic mice and in vitro thymic organ cultures. Using a panel of transgenic lines with
different expression levels of HA in the thymus, it was observed that Treg cell number
was enhanced at low expression levels, whereas high levels resulting predominantly in
negative selection [47]. A similar monophasic response was observed in vitro using a
titration of agonist peptides into fetal thymic organ cultures of NOD TCR transgenic cells,
in which Treg cell numbers were positively related to peptide dose at low concentration,
but diminished at high antigen concentration due to extensive negative selection [49].
This phenomenon was also replicated in vivo using intravenous peptide administration
[42]. Finally, a recent study using transgenic mice in which the level of antigen
presentation was decreased by the downmodulation of MHC class II expression in Aireexpressing mTEC cells also showed a shift from negative selection to Treg cell
development, which utilized a newly described transgenic of an Aire-promoter driven
shRNA against C2TA, a master regulator of MHC class II expression (C2TAkd) [41].
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Thus, the experimental evidence favors a model by which Treg cell development is most
efficient within an avidity window below that of negative selection.
While the current data provide a framework for understanding the role of avidity
and affinity in thymic Treg cell selection, a number of questions remain. One potential
issue is the use of transgenic lines in which there is only a single TCR clonotype. As
discussed above, the efficiency of Treg cell development can be heavily influenced by the
clonal frequency of the T cell [39, 40]. This complicates the interpretation of experiments
that increase the amount of antigen level as a means to understand avidity. The traditional
interpretation is that the increased number of ligands per APC leads to enhanced TCR
signaling and Treg cell selection. However, it may be possible that the increased amount
of antigen results in more APCs with sufficient ligand, enhancing the frequency of
Foxp3+ cells generated via an enlarged niche. Given that intraclonal competition also
affects positive selection [50, 51], albeit to a lesser degree, it is reasonable to expect that
negative selection is also affected by an antigenic niche. Thus, the analysis of Treg cell
differentiation versus negative selection may be quite different at high versus low clonal
frequencies.
Another issue is the use of antigen-transgenic lines driven by ubiquitous
promoters, peptide injection into mice, or addition of peptides to fetal thymic organ
cultures (FTOC), which presumes that Treg cell selecting ligands are fairly ubiquitous
and the APC environment of the thymus is monolithic. Experimental evidence suggests
that Treg cell selection utilizes a limited antigen niche [39], making ubiquitous antigens
less likely to model thymic Treg cell development. Moreover, the distribution of selecting
ligand on the various thymic APC subsets may or may not represent that of natural Treg
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cell ligands. For example, expression of antigen in the cortex might favor negative
selection rather than Treg cell development. However, these data may still be relevant as
the range of antigens that select thymic Treg cell development has yet to be fully
explored. Thus, although the current data show that affinity and avidity play important
roles in thymic Treg cell selection as proof of principle, future experiments will be
required to understand in a quantitative fashion how reactivity to self-antigens dictates
cell-fate choice between Treg cell differentiation, negative selection, and release from the
thymus as an effector cell with autoimmune potential.

A signaling threshold for thymic Treg cell development
One reason that it has been difficult to address the role of self-antigen reactivity in
Treg cell selection is the lack of effective in vivo assessment for TCR stimulation. While
T cell activation markers such as CD69 and CD25 are associated with the process of Treg
cell development [52], they did not provide compelling evidence due to their transient
expression or their upregulation as a Treg cell marker, respectively. Recently, a new
marker for TCR activation was reported using a Nur77 promoter driven GFP which
revealed several interesting aspects of thymic Treg cell differentiation [43].

In a

polyclonal population, they found that GFP expression was high on Foxp3+ compared
with Foxp3– cells, confirming the notion that Treg cells underwent TCR mediated
selection to agonist ligand.
More instructive, however, was the analysis of Nur77-GFP in G113 Treg TCR
transgenic cells that were known to be restricted by a small developmental niche [39].
One prediction was that intraclonal competition would result in a downward shift of a
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monophasic TCR signal measured by Nur77-GFP, thereby decreasing the proportion in
the "avidity" window of Treg cell development. However, what was observed was that
G113 cells existed in a biphasic plot with distinguishable Nur77-GFPhi and lo populations,
which shifted in proportion depending on the clonal frequency of G113 thymocytes.
Assuming that the Treg cell differentiation program itself does not affect Nur77-GFP
levels, these data suggest that intraclonal competition operates by limiting the number of
T cells obtaining a high level TCR signal, rather than decreasing the probability that a
lesser TCR signal leads to Foxp3 induction. Niche size would then reflect the number of
APCs that have sufficient antigen in terms of both affinity and avidity to induce "high
level" TCR signaling, which remains to be biophysically defined in the context of Nur77GFP. Thus, this suggests that Treg cell differentiation is dependent on a certain threshold
of TCR signaling, arguing for a "digital," rather than "analog" interpretation of TCR
signals for thymic Treg cell development.

Timing of thymic Treg cell differentiation: APC subsets
The notion that self-antigen specificity selects the thymic Treg cell population
engenders the question of which APCs are presenting what self-antigens. For example, it
is known that cTEC and mTEC present different antigenic repertoires due to the use of
distinct antigen processing enzymes [53]. Moreover, Aire expression in mTECs has been
shown to induce the expression of tissue-specific antigens in the thymus [54]. Other
differences between APCs such as co-stimulation may also affect thymic Treg cell
differentiation. Thus, it is important to understand the contribution of the various thymic
APC subsets in the generation of the thymic Treg cell population.
11

Initial studies suggested that a normal frequency of CD25+ Treg cells can be
generated when MHC class II is exclusively expressed in the cortex of the thymus [55].
Consistent with cortical Treg cell development, some studies showed a considerable
frequency of Treg cells at CD4+CD8+ (DP) stage [56, 57]. However, other studies favor
the notion that Treg cell differentiation mainly occurs at the CD4SP stage [58, 59]. The
temporal analysis of Treg cell generation during the neonatal period as well as in young
adults using neonatal bone marrow injection demonstrated that DP cells expressing
Foxp3 are rare and the development of Foxp3+ cells mostly starts at immature CD4SP
stage. Although a quantitative assessment of the relative contribution of cortical versus
medullary APCs to thymic Treg cell differentiation is not established, it appears that most
Treg cells are generated in the medulla.
In this thesis, I examined intrinsic and extrinsic factors for Treg cell development
in the thymus using TCR repertoire analysis, the affinity of TCR for self-antigen and
APC environment determining the developmental stage of Treg cells respectively. First,
in the study of TCR affinity, I demonstrated that thymic Treg cell development is directly
correlated with TCR affinity to self-antigen in a broad range. Second, I observed that
foreign antigen specific Treg cells can be generated by recognition of self-antigen via
presumably promiscuous antigen presentation by thymic APCs. Third, it was suggested
that high TCR affinity expands the number of APC delivering a Treg cell inducing signal.
Last, I found that the threshold for peripheral T cell responses is well above that for
thymic Treg cell development and correspond to that for negative selection, suggesting
that thymic tolerance mechanisms are developed to accompany escaping self-reactive
effectors with Treg cells to prevent autoimmune responses in the periphery. Also, in the
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study of developmental period of Treg cells, I demonstrated that the frequency of Treg
cells generated at DP stage is much smaller than previously suggested, and most Treg
cells differentiate at immature CD4SP stage, implying an important role of medullary
APC in facilitating efficient induction of Foxp3. Taken together, this dissertation study
suggests that Treg cell development is a default outcome of self-antigen encounter of
CD4 SP thymocytes, and TCR affinity for self-antigen instructs Treg cell development.

13

Chapter 2
Tuning of thymic Treg cell selection to the self-reactive peripheral immune response

Introduction
The adaptive immune system generates a diverse array of antigen receptors to
allow recognition of a variety of pathogens. However, a consequence of this diversity is
that some receptors will recognize self with the potential to cause autoimmunity. For T
cells, the issue of self-reactivity is mitigated as development occurs in a specialized organ,
the thymus, where the immature T cell population is educated to the self-antigenic
repertoire prior to their release into the periphery as mature T cells with the ability to
cause autoimmunity. One important mechanism of education is the deletion of selfreactive T cells, also known as negative selection [12, 13]. However, not all self-reactive
thymocytes are eliminated, and some escape the thymus as effector cells with the
potential to cause autoimmunity [15, 16]. A second mechanism of education to selfantigens is now recognized to be the differentiation of self-reactive thymocytes to
become Treg cells that suppress, rather than induce, inflammatory responses.
TCR specificity was initially thought to be important for thymic Treg cell
development as it was observed that TCR transgenic mice on a Rag-deficient background
do not have Treg cells [20, 60], implying that only certain TCRs can facilitate Treg cell
differentiation. Subsequent studies of TCR and antigen double transgenic mice suggested
that recognition of self-antigen was the pertinent requirement for thymic Treg cell
induction [60, 61]. Other reports using fetal thymic organ cultures (FTOC) and in vivo
14

peptide injection have supported this model [42, 49]. Taken together with other
studies[36, 39, 40], the preponderance of the data suggests that self-recognition is an
important requirement for thymic Treg cell selection.
While these studies provide proof of principle that self-reactivity is required to
trigger thymic education via Treg cell differentiation and negative selection, a number of
questions remain. First, many studies modeled interactions with ubiquitous antigens via
transgenic expression or peptide administration in vivo or in vitro [42, 49]. However,
recent data suggests that thymic Treg cell development utilizes a limited antigenic niche
[39, 40], implying that ubiquitous antigen presentation may not be an appropriate model.
Thus, the level of self-reactivity that elicits thymic education mechanisms for CD4 + T
cells to tissue-specific antigens is unknown.
Second, the study of TCR transgenic cells at high clonal frequencies may not
represent what happens during normal thymic development, which occurs at very low
clonal frequencies. For example, high clonal frequencies have recently been shown to
markedly decrease the efficiency of thymic Treg cell development, presumably due to
intraclonal competition [39, 40]. Thus, it may be possible that Treg cell development or
negative selection may be different at high versus low clonal frequencies.
Finally, while there have been studies of MHC class I restricted T cells regarding
thresholds of negative selection [16, 62], the range of TCR self-reactivities that elicit
thymic tolerance mechanisms in CD4+ T cells in vivo has not been examined. In some
studies, the level of self-reactivity required to trigger thymic Treg cell differentiation has
been suggested to be quite high [41, 61], being at or near the level of self-reactivity that
induces negative selection. Moreover, thymic Treg cell differentiation may be dependent
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on a certain threshold of TCR affinity for antigen, as Treg cell development was not
observed with low affinity interactions, even if the antigen was expressed at high enough
levels to induce negative selection [63]. On the other hand, it was reported that there was
great overlap between the Treg and non-Treg TCR repertoires [37], suggesting that a
broad range of self-reactivity, perhaps including TCRs that recognize self at the level of
positive selection, was sufficient for Treg cell development. Also, direct demonstration of
natural Treg TCR recognition of self-antigens presented on thymic APCs has not been
successful [37], suggesting that the antigen is rare or that the TCR affinity for antigen is
low. Determining the self-reactivity thresholds for thymic Treg cell induction and
negative selection would be useful for understanding how the immune system perceives
the problem of self-recognition and utilizes thymic education to control it. Thus, the
quantitative level of self-reactivity that triggers thymic education mechanisms, and how
that relates to level of self-reactivity required for peripheral immune responses, are not
known.
To address this question, I decided to fix the level of self-antigen and vary the
efficiency of TCR recognition. Since natural Treg ligands are currently unknown, I
utilized as a well-characterized model of a tissue-specific antigen, the RIP-mOVA
transgenic line, in which the rat insulin promoter drives the expression of membrane
bound ovalbumin (OVA) [64]. The developmental effects of thymic encounter with a
relatively rare "self-antigen" can then be assessed at low clonal frequencies of T cells
expressing a panel of naturally occurring TCRs with varying reactivity to OVA323-339
identified from DO11 TCR transgenic mice. Remarkably, I observed a direct correlation
between the degree of antigen-reactivity and thymic Treg cell generation over a broad
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~1,000-fold range. Negative selection was apparent with the more self-reactive TCRs.
Finally, peripheral responses as measured by proliferation of naive T cells after transfer
into irradiated RIP-mOVA mice required a degree of OVA-reactivity that induces both
thymic negative selection and Treg cell development. Thus, these data demonstrate that
the level of self-reactivity plays a crucial instructive role in thymic Treg cell
differentiation, which is tuned to be substantially below the threshold for peripheral
immune responses to self-antigen.
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Materials and Methods
1. Mice
Foxp3gfp mice [65] were a kind gift from A. Rudensky (MSKCC). RIP-mOVA
[64] mice Were obtained from Jackson Labs. DO11.10 TCRβ transgenic mouse line [66]
was kindly provided by K. Murphy (Washington U.). All mice were backcrossed onto
B6.C (B6 background congenic at the MHC locus with BALB/c) to facilitate breeding to
mutant mice of B6 background, and were bred to generate DO11.10 TCRβ transgenic
Foxp3gfp TCRα+/– RIP-mOVA mice for TCR analysis. CD45.1 RIP-mOVA mice were
also generated on the B6.C background. Mice were housed in a specific pathogen–free
animal facility and were used according to protocols approved by the Institutional
Animal Care and Use Committee at Washington University.

2. Reagents
The following monoclonal antibodies were from eBioscience, Biolegend and BD
Pharmingen: antibody to CD4 (RM4-5), anti-CD8 (53-6.7), anti-CD45.1 (A20), antiCD45.2 (104), anti-Thy-1.1 (HIS51), anti-CD25 (PC61), anti-HSA (M1/69), and anti–
TCR Vβ8 (F23.1). Chicken ovalbumin (OVA323-339) peptide (ISQAVHAAHAEINEAGR)
was purchased from GenScript Corp. CFSE, Cell-Trace Far-Red DDAO dye and CellTrace Violet Proliferation kit were purchased from Invitrogen. Recombinant mouse IL-3,
recombinant human IL-6, and recombinant mouse stem cell factor for the bone marrow
culture were obtained from Peprotech.
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3. Culture of T cells and TCR sequencing
Peripheral spleen and lymph node cells from DO11.10 TCRβ x Foxp3 gfp Tcra+/–
RIP-mOVA– or

+

mice were labeled with DDAO and cultured with 1μM of OVA323-339

for 5 days. DDAO low-Vβ8+ CD4 T cells were purified from Foxp3– and Foxp3+ subsets
by FACS (FACSAria, Becton Dickenson). Sequencing and analysis of TRAV14 TCRα
(Vα2) chains was performed as previously described [33].

4. Measurement of EC50.
For NFAT activation assay, T cell hybridomas expressing DO11 TCRβ, mCD4,
and an NFAT-GFP reporter [66], were retrovirally transduced with TCRα. FACS sorted
mCD4+Vβ8+Vα2+ cells were cultured with flt3 ligand-activated CD11+ APC and various
concentrations of OVA

323-339.

GFP expression was measured by flow cytometry 40 hrs

post stimulation. The NF-κB reporter cell line was generated by retroviral transduction
of NF-κB-GFP construct [67] provided by B. Sleckman, Washington U., into DO11
TCRβ-mCD4 T cell hybridomas, and then transduced with TCRα chains. In these assays,
the TA3 B cell hybridoma was used for APC to decrease background. To measure IL-2
production, 5KC T cell hybridomas expressing DO11β were transduced with a TCRα
chain, and cultured with TA3 APCs. The supernatants were assessed for IL-2 using a
CTLL-2 bioassay with Alamar blue (Arcus biologicals).
Thymic and peripheral T cells expressing an individual OVA peptide-specific
TCR were generated by retroviral bone marrow chimeras as described below.
Thymocytes were separated into CD4SP and DP subsets by magnetic cell purification
using biotinylated anti-CD8 antibody and anti-biotin microbeads (AutoMACS, Miltenyi
Biotec). CD4SP Were cultured with irradiated splenic APC pulsed with OVA323-339 to
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measure CD25 induction at 24 hours by flow cytometry. DP cells were also cultured
with APCs to measure down regulation of CD4 and CD8 at 48hrs by flow cytometry.
Pooled spleen and lymph node cells were labeled with CFSE and cultured with OVA323339.

Cell division of retrovirally transduced cells (CD45.2 + CD45.1– TCRβ+ Vα2+ CD4+)

was assessed by flow cytometry after 72 hours. To generate the dose response curve of
each TCR, the activation/expression level at each concentration of peptide was
normalized to that of anti-CD3 antibody (1µg/ml) stimulation, and EC50 was determined
by nonlinear regression using GraphPad software.

5. Tetramer binding
T cell hybridomas (2x105) expressing individual TCRs were stained with 20μg/ml
of PE labeled tetramers of I-Ad protein with linked DO11 OVA epitope [68] at 37°C for
90 min in round bottom 96-Well plates, and were further incubated with 2μg/ml of antiTCRβ antibody at 4°C for 30 min. Tetramer binding to TCRs was measured by MFI of
PE using flow cytometry. 3K:I-Ab tetramer was used as a control.

6. Retroviral transduction of TCR into CD4–CD8– thymocytes
Thymocytes from Foxp3gfpRag1-/- mice were transduced with MigR1-derived
retroviruses expressing TCRα-P2A-DO11 TCRβ IRES-Thy1.1 as described [69, 70].
One million cells in 10μl PBS was injected into the thymic lobe of sublethally irradiated
(600 rads) wild-type and RIP-mOVA recipients. Development of Foxp3+ thymocytes was
analyzed by flow cytometry 2 weeks later.
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7. Retroviral bone marrow chimeras
Generation of retroviral bone marrow chimeras have been previously described
[39]. Here, I used Foxp3gfpRag1–/– B6.C mice as bone marrow donors, which were at
times mixed with bone marrow of CD45.1 Foxp3gfp mice at ratios of 1:0, 1:1 or 1:4, prior
to injection (5x106 total cells) into lethally irradiated (1,000 rads) CD45.1 wild-type or
RIP-mOVA hosts. Thymic and peripheral T cells were used for experiments or analyzed
by flow cytometry 6 weeks later.

8. Assessment of negative selection in vivo
Thymocytes expressing individual TCRs were generated by retroviral bone
marrow chimeras (not mixed) in wild-type hosts. CD4SP cells were FACS sorted, and
mixed with Cell Trace Violet-labeled polyclonal thymocytes at a 1:1 ratio. CD4SP cells
were injected into the thymus of either CD45.1 wild-type or RIP-mOVA recipients, and
analyzed by flow cytometry on day 3 post transfer.

9. Assessment of peripheral responses to antigen in vivo
Peripheral CD4+ T cells expressing individual TCRs were generated by retroviral
bone marrow chimeras in wild-type hosts, and labeled with Cell Trace Violet as a CFSE
analog to follow cell division. Foxp3– CD4+ T cells (105) were intravenously transferred
into irradiated (500 rads) CD45.1 wild-type or RIP-mOVA recipients. Splenocytes were
analyzed for proliferation and Treg cell conversion 14 days later by flow cytometry.
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Chapter 2.1
Identification of OVA peptide-specific TCRs in a broad range of affinity

Results
Identification of naturally occurring OVA323-339 peptide-specific TCRs
The degree of self-reactivity that triggers thymic Treg cell differentiation of CD4 +
T cells is unknown, with studies favoring high [63] versus low [37] thresholds of selfreactivity. As different thresholds for thymic Treg cell development may be predicted to
generate different models regarding how self-reactive Treg and effector cells participate
in immune responses to self- and foreign antigens in the periphery (Figure 2.1A,B), I
sought to define this threshold using a panel of TCRs with varying self-reactivity.
Although mutagenesis has been used to generate TCRs with different affinity to antigen, I
decided to identify naturally rearranged OVA-reactive TCRs from the peripheral CD4+ T
cell population to avoid non-physiologic TCR interactions with peptide:MHC molecules.
As the frequency of OVA-specific T cells in the normal T cell population is very low, I
reasoned that using a TCR β-transgenic line from an OVA-specific TCR would increase
the precursor frequency based on observations from the MHC class I restricted OT-I
transgenic line [71]. Another advantage of fixing the TCR β-chain is that the physical
framework for TCR recognition of peptide:MHC molecules will be similar between
different TCR α-chains. I therefore obtained a TCR β transgenic line based on the
DO11.10αβ TCR [66], which recognizes OVA323-339 peptide at agonist level affinities [72,
73]. To ensure that only one TCR α chain is expressed per cell, the mice were bred to be
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Tcra+/–. Thus, I used DO11β Foxp3gfp B6.C (H-2d) Tcra+/– RIP-mOVA+ or – mice as a
source of T cells to identify a panel of OVA-specific TCRs (Figure. 2.2A).
To enrich for OVA-specific TCRs amongst the TCR β transgenic polyclonal
repertoire, I identified T cells that proliferated after in vitro stimulation with OVA
peptide using dilution of DDAO, a cellular dye similar to CFSE but compatible with GFP
(Figure 2.2B). However, there appeared to be substantial OVA-independent proliferation.
To identify OVA-specific TCRs, I looked for TCR sequences that were enriched in the
OVA-stimulated versus un-stimulated T cell populations.

I obtained 3,785 TCRα

sequences from Foxp3+ and Foxp3– cells from RIP-mOVA+ or – mice stimulated in vitro
with or without OVA-peptide (Figure 2.2C). I restricted the initial analysis to the
TRAV14 (Vα2) repertoire to limit the possible structural configurations of TCR
interaction with OVA peptide:MHC II molecules. As expected, there was substantial
overlap between the OVA stimulated and un-stimulated repertoires (Figure 2.3). In
particular, the 9 most frequent Foxp3- TCRs on T cells from RIP-mOVA+ mice were
found at comparable frequencies irrespective of OVA-peptide stimulation, suggesting
that the precursor frequency of OVA-specific cells is much lower in these mice due to
negative selection.
In order to confirm OVA-peptide specificity, I selected the most frequent TCRs
found in the OVA but not control cultures (highlighted in grey, Figure 2.3) and expressed
them on DO11β T cell hybridoma lines that contain GFP driven by NFAT as a reporter
for TCR stimulation [66]. Since the parent line prior to retroviral transduction was the
same, the hybridoma cells should differ only by the TCRα sequence, allowing direct
comparison of antigen recognition regardless of the cellular source of the TCR. However,
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only a subset of these TCRs showed reactivity to OVA peptide presented by Flt3L
induced dendritic cells (Figure 2.4), suggesting that low frequencies and well to well
variability limited the effectiveness of this subtraction approach.
In these screening experiments, I noted that the only TCRs which exhibited OVAreactivity, regardless of T cell subset or RIP-mOVA status, utilize TRAJ21 (Jα21), which
happens to be the same J-region utilized by the TRAV5D (Vα13) DO11αβ-chain. This
suggests that Jα21 provides structural features that facilitate recognition of OVA-peptide
in the context of DO11β. I therefore identified all naturally rearranged Jα21 containing
TCRs in our data set irrespective of frequency, T cell subset, or genotype, and tested
them for OVA-reactivity (Figure 2.5). Interestingly, only TCRs with a CDR3 length of 10
showed reactivity to OVA. Thus, I have identified a panel of 8 naturally arising TCRs all
with Jα21 and the same CDR3 length that recognize OVA-peptide:MHC class II I-Ad
(Figure 2.6), suggesting that these TCRs all recognize in a very similar manner OVA323339

bound to I-Ad in a single register.

The panel of TCRs exhibit a broad range of reactivity to OVA
To calculate the efficiency of OVA recognition, I determined the effective
concentration of OVA peptide that elicited half-maximal responses (EC50) for each TCR
using non-linear regression analysis (Figure 2.7A). As an inter-experiment control, the
peptide responses were normalized to that of anti-CD3 antibody treated cells. Since the
EC50 is dependent on the functional characteristics of the assay, I decided to use DO11αβ
as a reference TCR for a typical agonist level response to foreign antigen. Thus, the
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relative efficiency by which a TCR recognizes OVA peptide in comparison with DO11 is
denoted as Log(EC50) = Log(EC50 DO11) - Log(EC50 TCR).
The first quantification of the efficiency of OVA recognition utilized the NFATGFP reporter hybridoma cells generated for the initial functional screening above (Figure
2.6). I observed that our TCRs spanned over 3 logs in relative EC50 to our reference TCR
DO11, with TCRs N7 and N9 within 1 log of DO11, R1/R4 within the 2nd log, and R2,
N12, N13 and P1 with even lower reactivity to OVA. Note that changes in one or two
amino acids greatly affected the recognition of OVA, such that P1 exhibits greater than a
thousand fold-lower sensitivity to peptide antigen than DO11.10, although there may also
be effects in the CDR1/2 regions for R2 and N9 (Figure 2.6A). Thus, I have identified a
panel of 8 TCRs that recognize OVA with a broad range of efficiencies.

Thymic Treg cell selection of TCRs with foreign antigen-reactivity
I first wanted to establish that our panel of OVA-reactive TCRs does not facilitate
thymic Treg cell development in the absence of OVA, which would preclude
straightforward interpretation of OVA-dependent Treg cell generation.

I utilized

retroviral transduction of DN thymocytes followed by intrathymic transfer into
congenically marked hosts [69, 70] to assess the development of Foxp3+ cells 2 weeks
after transfer. I did not observe Treg cell development in T cells expressing the DO11
TCR, as well as five OVA-reactive TCRs (Figure 2.7B). Interestingly, there were three
TCRs which facilitated thymic Treg cell development in the absence of OVA, suggesting
that these TCRs may recognize unknown self-antigens for Treg cell selection. This is
further supported by the observation of R1 and R2 in the Treg TCR repertoires from
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wild-type mice (Figure 2.3). It appears that both TRAV14 subtype and CDR3 sequence
affects this presumed self-reactivity, as R2 and N9 use the same TRAV14 subtype but
different CDR3 sequence, whereas R1 and R2 utilize the same CDR3 sequence, but have
different TRAV regions. Thus, these data demonstrate that it is possible to generate Treg
cells in the thymus that also recognize foreign antigens, presumably due to the
promiscuity of TCR recognition.
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Figure Legends

Figure 2.1. Hypothetical models on the relationship between thresholds for thymic
Treg cell selection and peripheral tolerance and immunity.
(A) High threshold of self-reactivity model for thymic Treg cell selection. Selfreactive TCRs above a high threshold are selected into Treg cells, which prevent
autoimmunity elicited by lower affinity T cells. In this model, there is no selection of
Treg cells to foreign antigens, allowing effector T cells to efficiently respond to foreign
antigens. Blue circles represent self-reactivity at the level of positive selection, and
maroon circles self-reactivity at varying levels as indicted by the darkness of the fill color.
Treg cells are indicated in shades of green fill color. (B) Low threshold of self-reactivity
model. In this model, a broad repertoire of Treg cells is generated with low correlation to
self-reactivity. Tolerance to self occurs as Treg cells are generated to most antigenspecificities. However, Treg cells will also be generated to foreign antigens, and has
been proposed to prevent excess immunopathology that can be occurred during immune
responses to pathogens. (C) Our data suggest that thymic Treg cell generation is best
represented by an intermediate model as it is directly driven by self-reactivity over a
broad range, but is above the level of positive selection. In this model, foreign antigenreactive thymic Treg cells arise due to incidental self-reactivity of the TCR, presumably
related to promiscuous antigen recognition. For negative selection, the shape of the curve
is not known (indicated by dashed line and ?). For positive selection, the range of
affinities is not well established (indicated by dashed line). Int., intermediate.
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Figure 2.2. TCR sequencing of OVA peptide-reactive T cells
(A) Flow cytometry of the thymic and splenic CD4 + T cells from DO11β Foxpgfp
Tcra+/– RIP-mOVA–

or +

mice. (B) Gating scheme for sorting of proliferating cells after in

vitro activation with OVA-peptide. DDAO is a dye analogous to CFSE that is used to
determine cell division. The percentage of cells in each quadrant is indicated by the
number. Boxes with dashed lines represent the gates used to sort proliferating Foxp3 – or
Foxp3+ cells. (C) Numbers of TCRs sequenced from the sorted cell populations indicated
in (B). Each experiment represents pooled spleen and lymph nodes from 2 mice. TCR
sequence database was generated by pooling sequences from all experiments.

Figure 2.3.

Selection of possible OVA peptide-reactive TCRs using repertoire

analysis
The 20 most frequent TCRs are shown for Foxp3+ and Foxp3– cell subsets from
RIP-mOVA– or + mice (numbers in blue). TCRs found only in the OVA peptide culture
were presumed to be OVA reactive and cloned for functional screening using hybridoma
cells (highlighted in grey). TRAJ21 TCRs are shown in red. Note that R1* and R2**
TCRs of the same CDR amino acid sequence are distinguished by usage of polymorphic
TRAV14-3*01 and TRAV14D-1*01, respectively. Numbers in the table represent the
frequencies of the TCR in each subset.

Figure 2.4. Confirmation of OVA peptide-reactivity
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TCRs selected from the repertoire analysis in Figure 3 were retrovirally expressed
on the NFAT-GFP reporter hybridoma line. TCRs selected from Foxp3– RIP-mOVA–
cells were also tested, but did not have any OVA-reactive TCRs not shown above. TCRs
that contain TRAJ21 sequence in their CDR3 are shown in red as Supplementary Figure
3. One TRAJ21 TCR did not show reactivity to 1 mM OVA peptide in vitro (†), and one
did not express in vivo in the TCRα-P2A-DO11β vector for unknown reasons (‡). These
two TCRs were therefore not studied further. Data are representative plots from two
independent experiments.

Figure 2.5. Screening of TRAJ21 containing TCRs
(A) Summary of all TRAJ21 TCRs found in our TCR database. TCRs that
induced NFAT-GFP expression are highlighted in grey with differences in amino acid
sequence marked in red. (B) Flow cytometry of NFAT-GFP expression by TCRs in (A).
Data are representative plots from two independent experiments.

Figure 2.6. TCRs exhibit a broad range of reactivity to OVA peptide.
(A) Summary of sensitivity to OVA-peptide for 9 TCRs including DO11.
Sensitivity to OVA-peptide was determined using an NFAT-GFP hybridoma as discussed
in Figure 7A. (B) Flow cytometric plots of NFAT-GFP expression by hybridoma cells
expressing OVA-reactive TCRs in (A) after stimulation with Flt3L-induced DCs and 1
mM OVA peptide. (C) Expression levels of retrovirally transduced TCRs on hybridoma
cells. Data are representative from three independent experiments.
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Figure 2.7. In vitro and in vivo analysis of OVA-reactive TCRs
(A) In vitro assessment of TCR sensitivity to OVA peptide. NFAT-GFP reporter
hybridomas expressing each of 9 TCRs, including DO11 (red), was generated via
retroviral transduction of TCRα chains, and tested against a range of OVA peptide
concentrations presented by Flt3L induced dendritic cells. Data shown are the frequency
of NFAT-GFP+ cells normalized to that of αCD3 antibody treated cells for each
hybridoma line. Data are representative of three independent experiments. (B) In vivo
assessment of thymic Treg cell development. Double-negative (DN) thymocytes from
Foxp3gfpRag1–/– were retrovirally transduced with each OVA-specific TCR and
transferred into the thymus of wild-type mice, and analyzed for Treg cell generation 14days post transfer.

Data are representative of 3-4 mice for each TCR from at 2

independent experiments.
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Figure 2.1. Hypothetical models on the relationship between thresholds for thymic
Treg cell selection and peripheral tolerance and immunity.
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Figure 2.3. Selection of possible OVA peptide-reactive TCRs using repertoire
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Figure 2.4. Confirmation of OVA peptide-reactivity
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Figure 2.6. TCRs exhibit a broad range of reactivity to OVA peptide.
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Figure 2.7. In vitro and in vivo analysis of OVA-reactive TCRs
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Chapter 2.2
A role of TCR affinity in thymic tolerance mechanisms and self-reactive peripheral
immune response

Results
TCR affinity is a primary determinant for thymic Treg cell development
To avoid the complication of OVA-independent Treg cell generation, I decided to
focus on the 6 TCRs, including DO11, which did not facilitate thymic Treg cell
development in wild-type mice. The differences between the 5 TCRs are only in the
CDR3 amino acid sequence, as all of these TCRs use the same TRAV14-3*01 subtype.
Because measurement of OVA reactivity so far was based a single readout using the
NFAT-GFP reporter, I sought to expand the analysis of functional responses to TCR
stimulation. I utilized another marker, NF-κB-GFP, which was introduced into the same
parent hybridoma line used by NFAT-GFP [66].

Since this parent hybridoma line

produced little IL-2, I tested IL-2 production after re-expressing these TCRs in a different
TCR-deficient hybridoma line, 5KC-73.8.20 [74]. Although the range of measured EC50s
varied from ~50-5,000 fold depending on the assay, the ordering of TCRs in terms of
efficiency of OVA recognition remained mostly constant (Figure 2.8A, Table 2.1).
Since TCR signaling may differ between hybridoma cells and primary T cells, I
also assessed peptide reactivity using thymocytes and peripheral T cells. T cells
expressing individual OVA peptide-reactive TCRs were generated using retroviral bone
marrow chimeras using Rag1–/– donors. The EC50 for each TCR was determined in vitro
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by assessing down-regulation of co-receptors CD4 and CD8 on CD4+CD8+ (double
positive, DP) thymocytes, CD25 upregulation on CD4+CD8– (CD4 single positive,
CD4SP) thymocytes, and proliferation of peripheral CD4+ T cells (Figure 2.8B). Similar
to the results obtained using hybridoma assays, the OVA-specific TCRs showed a broad
range of sensitivity such that the least reactive TCR P1 was ~300-6,000 folds less
efficient than DO11.10 at recognizing OVA (Table 2.1). Thus, the data from 6 different
hybridoma and primary T cell assays agree that these 6 TCRs exhibit a broad range of
sensitivity for OVA recognition.
To estimate the TCR affinity for peptide:MHC, I measured the mean fluorescence
intensity (MFI) of equilibrium tetramer binding, which provides a relative assessment of
monomeric TCR:pMHC affinity [75-77]. Consistent with the functional assessment of
OVA-reactivity, tetramer binding classified N7and R4 as higher affinity TCRs (Figure
2.8C) in comparison with N12, N13, and P1, which showed little to no binding.
Although the latter 3 TCRs can elicit in vitro responses to OVA-peptide, these TCRs are
below the affinity range that can be quantified using this tetramer binding assay. Thus,
these tetramer data suggest that this panel of TCRs recognize OVA peptide:MHC with a
broad range of affinities.
I next assessed the ability of thymic OVA expression via RIP-mOVA to induce
thymic Treg cell development using retroviral transduction of TCRs into Rag1–/–
thymocytes followed by intrathymic transfer as described above. As expected, DO11
facilitated thymic Treg cell development in the presence of RIP-mOVA [78].
Interestingly, all of the other TCRs except for P1, the lowest-affinity TCR, induced Treg
cells to a degree that varied with the efficiency of OVA recognition (Figure 2.9 A,B).
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Treg cell generation could even be detected in cells expressing the low affinity TCRs
N12 and N13, which could not be reliably measured by equilibrium tetramer binding, and
require ~1200 fold (average of responses in 6 assays between P1 and DO11 in Table 2.1)
more antigen to achieve the same response in comparison to DO11. However, I was
unable to observe Treg cells generated by P1, which is very close to N13 in its sensitivity
to OVA. Although stochastic expression of RIP-mOVA in thymic mTEC cells may
contribute to mouse to mouse variability [79], differences between TCRs were readily
observed. Thus, these data show that TCRs which are on average one hundred to one
thousand fold less sensitive than DO11 can generate thymic Treg cells, demonstrating
that Treg cell differentiation can occur within a broad range of self-reactivity.
Linear regression analyses for all assays revealed that the ability of TCRs to
facilitate Treg cell generation is directly proportion to their affinity for OVA peptide as
provided by RIP-mOVA (Figure 2.9C). The efficiency of self-recognition was also
directly correlated with the generation of Foxp3–CD25+ cells (Figure 2.9D,E), consistent
with the proposal that the process of thymic Treg cell generation occurs via TCRdependent generation of Foxp3– Treg precursor cells [52]. Thus, these data demonstrate
that the degree of self-recognition is the primary determinant for Treg cell differentiation
in the thymus.

Treg cell selection niche is dependent on TCR affinity for self-antigen
Thymic Treg cell selection utilizes a small "niche" based on the observation of
intraclonal competition in studies of transgenic mice using naturally arising Treg TCRs
[39, 40]. Since the natural ligands for these Treg TCRs are unknown, the factors that
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affect this developmental niche are unknown. I therefore asked whether affinity to selfantigen affects the size of the Treg cell developmental niche. Since the intrathymic
transfer of retrovirally transduced thymocytes does not assess Treg cell generation at
steady state, I decided to analyze retroviral bone marrow chimeras using the two highest
affinity TCRs along with DO11. Various ratios of congenically marked wild-type bone
marrow was added to achieve varying clonal frequencies. I confirmed that these OVAreactive TCRs did not facilitate Treg cell generation in wild-type mice, even at low clonal
frequencies (Figure 2.10A). Consistent with previous reports [39, 40], I observed that
Treg cell development with all 3 TCRs was inversely correlated with clonal frequency in
the presence of OVA peptide presentation (Figure 2.4A). Moreover, the efficiency of
Treg cell generation was directly correlated with affinity, as evidenced by the ability of
higher affinity TCRs to generate a higher frequency of Treg cells at a given clonal
frequency (Figure 2.10B). The affinity of the TCR also correlated with the absolute
number of Treg cells that are generated in the thymus, implying that higher affinity TCRs
have a larger niche size for thymic Treg cell development (Figure 2.10C,D). Since the
amount of antigen generated by the RIP-mOVA transgene should be equal between
different bone marrow chimeras, I hypothesize that niche size in this case represents the
number of APCs that present sufficient antigen to trigger Treg cell selection for a given
TCR affinity.

Threshold for negative selection
Some studies using TCR transgenic models have reported negative selection to be
coincident with Treg cell generation [32, 61], whereas other studies have suggested that
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Treg cell selection may occur without obvious negative selection [39]. Thus, the level of
self-reactivity requwered to elicit Treg cell differentiation versus negative selection
remains poorly defined.
An interesting observation from our studies of clonal frequency and Treg cell
development was that the frequency of Treg cells using the higher affinity TCRs, DO11
and N7, actually Int down again at clonal frequencies below 0.1% (red box, Figure
2.10A). This was not apparent for the intermediate affinity TCR R4, nor for other TCRs
tested in previous reports [39], although it remains possible that this could be observed if
loIr clonal frequencies could be achieved experimentally. One possible explanation for
this observation is that TCRs with high affinity to antigen can induce negative selection
rather than Treg cell differentation at low clonal frequencies. In this case, the remaining
Foxp3– CD4SP cells have presumably have not yet encountered antigen.
To test the hypothesis that negative selection to RIP-mOVA occurs with T cells
expressing TCRs N7 and DO11, but not R4, I assessed whether purified CD4SP
thymocytes from retroviral bone marrow chimeras in wild-type hosts would be deleted
after intrathymic transfer into RIP-mOVA+ recipients. At day 3 post-transfer, I observed
that the relative ratio of thymocytes expressing the higher affinity TCRs DO11 and N7,
but not R4, to the co-injected polyclonal thymocytes Were decreased in RIP-mOVA
hosts, indicative of negative selection (Figure 2.11). Consistent with previous reports
[63], these data suggest that the propensity to induce Treg cell differentiation does not
always rescue the cells from negative selection. Since R4 is approximately 15-fold
(average of 6 assays, Table 2.1) less efficient at recognizing OVA than DO11, these data
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suggest that detectable negative selection occurs at a substantially higher affinity
threshold than Treg cell selection.

Differential affinity thresholds for thymic Treg cell development and peripheral
responses to self
These studies in the thymus suggest that a broad range of TCR affinity can elicit
Treg cell development, albeit at varying degrees. As the affinity for self-antigen
decreases, the percentage of Foxp3– conventional T cells emigrating from the thymus
increases. Thus, understanding the relationship between the range of affinities that
facilitate thymic Treg cell generation versus peripheral responses is important for
clarifying the how self-reactive Treg cells may mediate self-tolerance in the periphery.
To address this question, I adoptively transferred peripheral Foxp3– CD4 T cells
bearing OVA-reactive TCRs into sub-lethally irradiated RIP-mOVA recipients, as no
proliferative responses were observed in non-irradiated mice. Intriguingly, the
intermediate affinity TCR R4 or low affinity TCR N12 did not respond to OVA in vivo
under these conditions (Figure 2.12 A, B). By contrast, the higher affinity TCRs DO11
and N7 induced peripheral expansion of Foxp3– cells as well as a small amount of Treg
cell differentiation (Figure 2.12 A, B). Consistent with previous observations [80],
peripheral Treg cell generation occurred on cells with less proliferation (Figure 2.12 C).
Interestingly, the affinity threshold for response to this peripheral self-antigen is similar
to that of thymic negative selection, whereas the threshold for thymic Treg cell
development is almost 100 fold lower (average R4 versus P1 sensitivity to OVA, Table
2.1). Thus, these data suggest a model where thymic Treg cell differentiation is tuned
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such that T cells with sufficient self-reactivity to elicit peripheral immune responses
cannot wholly escape the thymus as effector cells, and will always be accompanied by
thymically generated Treg cells (Figure 2.1C).
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Figure Legends

Figure 2.8. Defining efficiency of OVA recognition using hybridoma and primary T
cells.
(A) Hybridoma assays. Hybridoma cells expressing OVA-specific TCRs were
assessed for NF-κB-GFP expression (left) and IL-2 production (right) in response to
varying amounts of OVA peptide presented by TA3 APCs. (B) Assays of TCR reactivity
using primary thymocytes and peripheral T cells. T cells were obtained from retroviral
bone marrow chimeras using wild-type hosts. DP thymocytes were assessed for downregulation of CD4 and CD8 coreceptors in response to Flt3L DCs and varying
concentrations of OVA peptide (left).
upregulation (middle).
proliferation (right).

CD4SP thymocytes were tested for CD25

Finally, peripheral CD4 + T cells were tested for in vitro
Non-linear regression analysis and calculation of EC50 was

performed as per Figure 7a, and summarized in Table 2.1 as ∆EC50. Graphs shown are
representative of three independent experiments. (C) Binding of OVA:I-Ad tetramer to
hybridoma cells expressing OVA-reactive TCRs. Representative plots are shown on the
left, and summarized on the right (mean ± s.d., n=3 independent experiments). 3K:I-Ab
tetramer was used as a control.

Figure 2.9. Thymic Treg cell generation is instructed by the level of TCR reactivity
to self-antigen.
(A) Flow cytometry of Treg cell generation by OVA-reactive TCRs in the
presence of RIP-mOVA. Retrovirally transduced Rag1–/– DN cells were transferred into
thymus of RIP-mOVA mice, and were analyzed at 2 weeks as in Figure 2.7 B. (B) Data
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in (A) are summarized, with each dot representing the frequency (left) and absolute
number (right) of Foxp3+ cells from an individual recipient. The plot in the middle shows
the mean Foxp3+ percentage (± S.E.M.) correlated with the Log(EC50) of the TCR for
NFAT-GFP activation as compared with DO11. Foxp3+ cells were not detected (n.d.)
with the P1 TCR. (C) Correlation of Treg cell generation with in vitro sensitivity to
OVA. To determine whether TCR affinity is directly correlated with the efficiency of
Treg cell selection in vivo, I plotted the in vivo efficiency of Treg cell generation versus
the Log(EC50) of the TCR as compared with DO11, and analyzed it by linear regression.
For tetramer binding, I used the Log(MFI) as compared with DO11. Each symbol
represents an individual TCR indicated in the legend. (D) The frequency of Foxp3–
CD25hi CD4SP cells in the experiments described in (A) are shown (mean ± s.d., 5
independent experiments). (E) Correlation of Foxp3–CD25hi CD4SP cells with sensitivity
of TCR to OVA peptide. Frequencies of Foxp3-CD25hi cells shown in (D) were plotted
as per (C).

Figure 2.10. A role for TCR affinity in the thymic Treg cell selection “niche”
(A) Inverse relationship between clonal frequency and thymic Treg cell
development.

Thymic Treg cell development was assessed in mixed bone marrow

chimeras with varying ratios of wild-type to retrovirally transduced bone marrow. Data
shown are the percentage of Foxp3+CD4SP cells versus the clonal frequency in the
CD4SP subset for the indicated TCR. Each symbol represents data from an individual
recipient from 2-3 independent experiments for each TCR. Data points in the dashed red
boxes fall outside of the previously described inverse relationship. (B) Data from the
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experiment shown in (A) are plotted log-log to illustrate the similar slopes, with
differences in the intercept. Note that the points in the red boxes are not shown in this
plot. (C) Absolute numbers of Treg cells from the data shown in (B) are plotted versus
clonal frequency. (D) Correlation of Treg cell selection niche size to TCR affinity. The
number of Foxp3+ cells was analyzed by linear regression with OVA-reactivity measured
by NFAT activation (left) and tetramer binding (right) as per Figure 2.9. Each symbol
represents an individual TCR as indicated in the legend.

Figure 2.11. Treg cell development coincident with negative selection by high
affinity TCRs
(A) Assessment of negative selection of CD4SP thymocytes. OVA-reactive
CD4SP thymocytes and Cell-tracker violet labeled WT cells were intrathymically
injected into wild-type and RIP-mOVA mice. Flow cytometry was performed 3 days
later. Representative FACS plots are shown discriminating the injected wild-type and
OVA-specific CD4SP cells marked as blue numbers (left), and the TCR transduced
population (right). No Treg cells were observed in wild-type recipients for all TCRs
tested (not shown). (B) Negative selection as assessed by the ratio of OVA-specific
CD4SP cells to WT cells added as an injection control. Each dot represents an individual
recipient, with 2 independent experiments per TCR. Statistical differences were accessed
by unpaired t test. (C) Summary of negative selection experiment in (B). The percent
difference in the mean values from wild-type hosts compared with RIP-mOVA hosts is
shown for each TCR.
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Figure 2.12. High affinity TCR recognition of peripheral self-antigen is required to
elicit peripheral T cell responses.
(A) Assessment of peripheral T cells responses. Naïve peripheral Foxp3 –CD4+ T
cells were intravenously transferred into sublethally irradiated RIP-mOVA hosts.
Preliminary experiments did not reveal proliferation in non-irradiated hosts.
Representative flow cytometry plots are shown of the transferred splenic T cells after 14
days to determine proliferation via dilution of cell-tracker violet dye. (B) Summaries of
frequencies of proliferated (left) and Foxp3+ (right) cells–see gating in (A). Each dot
represents data from a single recipient, with 2 independent experiments per TCR. (C)
Peripheral conversion is inversely correlated with proliferation. Dilution of cell-tracker violet is
shown for Foxp3+ (dark line) and Foxp3– (grey shading) cells.
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Hybridoma†

T cells†

Clone

CDR3 a.a
Sequence

DO

AASPNYNVLY

N7

AACPNYNVLY

-0.2±0.2

-0.3±0.1

-0.1±0.1

-0.8±0.2 -0.9±0.6

-0.7±0.2

-0.30±0.03

Neg./Treg

R4

AAVPNYNVLY

-1.2±0.5

-0.5±0.2

-0.7±0.2

-0.9±0.1 -1.6±0.6

-1.3±0.5

-0.84±0.04

Treg

N12

ATTPNYNVLY

-2.6±0.2

-1.3±0.5

-1.5±0.3

-1.7±0.2 -2.3±0.7

-2.1±0.6

≤-1.30±0.05

Treg

N13 AASKNYNVLY

-3.5±0.2

-1.6±0.3

-2.2±0.4

-2.0±0.2 -3.0±0.9

-3.8±0.3

≤-1.35±0.04

Treg

-3.7±0.3

-1.7±0.3

-2.7±0.2

-2.5±0.3 -2.1±0.5

-3.0±0.4

≤-1.34±0.05

Tconv

P1

†
‡

AAPPNYNVLY

NFAT
NFκB
IL-2
activation activation production

CD4/8
on DP

CD25 on CD4 T cell
CD4SP proliferation

Tetramer
binding‡

Thymic
Selection
Neg./Treg

The relative sensitivity of OVA recognition is shown as the difference of Log (EC50) from that of DO11.
The relative affinities of TCRs are shown as the difference of Log (MFI) from that of DO11.

Data shown are mean ± s.e.m. (n=3).
Thymic selection is based on in vivo assays presented throughout the paper. Neg., negative selection. Treg,
Treg cell selection is observed.

Table 2.1. Summary of assessments of TCR reactivity
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Figure 2.8. Defining efficiency of OVA recognition using hybridoma and primary T
cells
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Figure 2.9. Thymic Treg cell generation is instructed by the level of TCR reactivity
to self-antigen.
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Figure 2.10. A role for TCR affinity in the thymic Treg cell selection “niche”

52

Figure 2.11. Treg cell development coincident with negative selection by high
affinity TCRs
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C

Figure 2.12. High affinity TCR recognition of peripheral self-antigen is required to
elicit peripheral T cell responses.
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Discussion
Although previous studies provided proof of principle that self-reactivity is an
important factor for thymic Treg cell differentiation and negative selection, there was
little sense of how much self-reactivity is required at low clonal frequencies.
Quantification of the relationship between self-reactivity and thymic Treg cell selection is
important for understanding how thymic Treg cells may provide tolerance in the
periphery. A high threshold of self-reactivity for Treg cell differentiation [63] would
predict that many low-affinity self-reactive T cells would escape the thymus as effector
cells, relying primarily on the presence of high affinity self-reactive Treg cells to provide
tolerance. By contrast, a low threshold of self-reactivity for Treg cell differentiation
would broaden the Treg cell repertoire such that it may almost approximate that of the
effector cell repertoire [37], increasing the likelihood that thymic Treg cells will
participate in not only immune responses to self, but also non-self antigens. Thus,
understanding the relationship between self-reactivity and thymic education mechanisms
would be useful to discriminate between these potential models for establishing selftolerance.
I addressed this question by analyzing a panel of TCRs with different affinities for
OVA peptide:MHC molecules for their in vivo response to the RIP-mOVA model
antigen. While using a single antigen transgenic line has technical advantages as it should
fix the amount and distribution of the antigen, another important consideration is that it
models a tissue specific, rather than ubiquitous, antigen. Whereas T cell autoimmunity to
ubiquitous antigens is not well described, tissue specific antigens are likely targets in a
number of human autoimmune diseases such as Hashimoto’s thyroiditis and type 1
55

diabetes. Thus, understanding tolerance to a model tissue specific antigen may be
clinically relevant.
These data suggests that tolerance mechanisms to tissue specific antigens
expressed in the thymus are broad and robust. I was surprised to observe that Treg cell
development to this model tissue-specific self-antigen still occurs with TCRs which are ~
1000 fold less sensitive to OVA peptide in comparison with the reference TCR DO11,
which represents a typical agonist interaction with foreign antigen. Although I did not
perform a direct measurement of affinity, the steady state tetramer binding studies in
conjunction with the broad range of functional assessments of TCR reactivity provide a
clear estimate of relative affinity for this panel of TCRs compared with the DO11 TCR.
It is interesting to contrast these results from analysis of negative selection of a CD8 +
TCR, in which a narrow affinity range was observed [13]. Whether this is explained by
differences in the assays used, or whether this reflects a fundamental difference between
T cells at different stages of development or MHC restriction, will need to be clarified by
future studies. None-the-less, in contrast with CD8 negative selection, the range of
affinity that the immune system considers of sufficient self-reactivity to warrant thymic
Treg cell generation is extremely broad.
I also observed that the level of self-reactivity is directly correlated with the
efficiency of thymic Treg cell generation.

In fact, thymic Treg cell development

appeared indistinguishable from any other in vitro or in vivo TCR-dependent process.
These data therefore support the notion that one of the primary purposes of TCR
activation this particular stage in development is Treg cell generation, which appears to
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wane during T cell maturation [59, 81]. Thus, the TCR's autoimmune potential dictates
its ability to generate thymic Treg cells.
The relationship between TCR affinity and the efficiency of thymic Treg cell
generation is also manifest in the apparent “niche” size, e.g. the number of Treg cells
generated, even though the physical antigen niche is likely stable due to the use of single
transgenic line to express OVA as “self-antigen.” This may arise via two possible
mechanisms. One is that the stronger the TCR signal is interpreted in an analog manner
increasing the likelihood that Foxp3 will be induced. Alternatively, the TCR signal is
interpreted in a digital manner such that only APCs that present sufficient antigen can
induce Foxp3 by exceeding a threshold of TCR signaling. Increased affinity would
therefore expand the number of APCs that could generate sufficient TCR signals.
Although direct evidences to test these hypotheses are required, the former model would
predict that TCR affinity would affect the slope of Treg cell generation as clonal
frequency decreases. Rather, I observed that TCR affinity shifted the entire curve with
almost same slope, such that higher TCR affinities resulted in enhanced Treg cell
generation at higher clonal frequencies, suggestive of a larger developmental “niche.”
Moreover, a recent study of TCR activation using a Nur77-GFP reporter is consistent
with a signaling threshold for Treg cell development [43]. Thus, I favor the interpretation
that higher TCR affinity increases the number of APCs that can deliver a threshold level
of TCR stimulation.
Although the affinity of the TCR for self-antigen and the Treg cell niche size is
directly correlated, this may only be true at higher clonal frequencies for TCRs with
agonist level affinity for self-antigen. It appears that negative selection likely perturbs
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this linear relationship at lower clonal frequencies, as T cells encountering self-antigen
are often deleted instead of becoming Treg cells. While it has been difficult to quantify
the role of intraclonal competition for negative selection, this may be expected based on
studies of Treg cell development [39, 40] and positive selection [50].
The threshold of observable negative selection appears to be substantially higher
than that of Treg cell differentiation. However, it must be noted that the sensitivity of
detecting Foxp3 induction as determined by the induction of Foxp3 gfp is excellent,
whereas measuring the loss of cells is comparatively insensitive. It may be possible that
negative selection occurs at lower affinity, but cannot be measured. However, trace
levels of negative selection is unlikely to have any impact on immune tolerance, as
essentially the same number of self-reactive T cells escapes the thymus, whereas a small
amount of Treg cell development may have a substantial impact due to the importance of
Treg cells in dominant tolerance.
Thymic Treg cell generation may be considered a window into how the immune
system perceives the need to combat self-reactivity during development prior to the
export of cells into the periphery. In comparison with thymic responses, I found that the
TCR affinities requwered for peripheral T cell responses were much higher than that
requwered for thymic Treg cell selection, and rather more similar to that requwered for
negative selection. While these data wwell need to be validated for other model selfantigens, and if possible, true self-antigens if they can be genetically changed without
affecting function, this suggests that the range of self-reactivity requwered for Treg cell
selection is substantially below that requwered for peripheral T cell responses.
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In summary, these data using a model tissue specific antigen suggest that the
immune system utilizes straighforward rules for determining the thymic Treg cell
population. Self-reactivity within a broad range, but above that for positive selection,
selects for Treg cells in a graded manner depending on the extent of self-reactivity.
Cognate, or agonist levels of self-reactivity also result in negative selection. In this
manner, the immune system selects for a Treg cell population which is highly tuned
towards high affinity self-antigen recognition while including some low affinity TCRs.
Together with deletion of high affinity TCRs, these rules imprint the self-antigen
repertoire on the Treg cell population. Interestingly, I found that incidental self-reactivity
can also clearly generate Treg cells to foreign antigens, which is consistent with studies
showing that a small fraction of cells binding to tetramers of foreign antigens are Treg
cells [82]. Thus, self:non-self discrimination likely revolves around the quantitative bias
of the TCRs amongst the Treg and naïve T cell population.
These data clarify how self-reactivity in the CD4+ T cell subset is constrained by
the immune system. Based on these data, I would predict that the bulk of the TCRs that
cause autoimmune disease would be of higher affinity than R4, which is ~ 15 fold less
sensitive than DO11. These TCRs are low enough affinity to avoid marked negative
selection and incompletely drive thymic Treg cell selection, permiting the escape of selfreactive naïve T cells [16]. Under normal circumstances, it is difficult to imagine that
these escaped self-reactive T cells could overcome the suppression by the thymic Treg
cell population concomitantly generated in response to a broad range of self-reactivity. It
seems that pro-inflammatory conditions that obviate or block Treg cell suppression
would be requwered to release these potential autoimmune effector cells.
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Such an

inciting event is often not obvious in spontaneous human autoimmunity. One interesting
future question is whether the B6 genotype studied here has an unusually low threshold
for thymic Treg cell generation, as it is known to be resistant to spontaneous
autoimmunity. Perhaps other autoimmune prone backgrounds wwell requwere a higher
threshold of self-reactivity for thymic Treg cell generation. Alternatively, these robust
thymic mechanisms may hint at the possibility that spontaneous autoimmunity may not
result from a failure of central tolerance, but rather occurs to antigens that are poorly
expressed in the thymus. For example, no indication was found in mixed bone marrow
chimeras that the self-reactive TCR 2D2 induces thymic Treg cell generation even at low
clonal frequencies (not shown), suggesting that the MOG-epitope is either not presented
in the thymus or the affinity of the 2D2 TCR for MHC-MOG peptide complex is too low
relative to the amount of thymic MOG-peptide. Future studies wwell be required to test
the hypothesis that sponatneous autoimmunity is primarily a failure of peripheral
tolerance.
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Chapter 3
Rare development of thymic Treg cells at CD4+CD8+ subset

Introduction
Natural CD4+Foxp3+ Treg cells are essential for preventing autoimmunity [83].
Although peripheral generation of Treg cells has been demonstrated [84], recent studies
suggest that the majority of peripheral Treg cells arise via thymic Treg cell development
[33-35, 85]. One popular model for thymic Treg cell development is that Treg cells are
selected based on TCR avidity for self-antigens at a level between positive and negative
selection [61], which is supported by studies demonstrating that the thymic Treg and nonTreg TCR repertoires differ [33-35, 52]. Thus, TCR specificity for self-antigens appears
to play an important role in Treg cell development.
As the APCs encountered by thymocytes can differ substantially between certain
steps in thymic development [86, 87], the stage at which self-reactive thymocytes become
Treg cells may play an important role in determining the TCR repertoire of the natural
Treg cell population. DP cells are typically found in the thymic cortex, in which the
predominant APCs are cortical thymic epithelial cells (cTECs). By contrast, mature
CD4SP cells are typically found in the medulla, where medullary thymic epithelial cells
(mTECs) and bone marrow derived dendritic cells are commonly found. These different
APC subsets appear to utilize different lysosomal proteases for antigen processing, as
cTEC use cathepsin L, whereas thymic dendritic cells and mTEC dominantly use
cathepsin S [53]. In addition, expression of the transcription factor Aire expands the
array of tissue-specific antigens presented by mTECs [88], which may be important for
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Treg cell selection [46]. These data therefore suggest that the antigenic environment
likely differs for DP versus CD4SP cells.
Several studies have demonstrated that Foxp3+ Treg cell lineage commitment can
occur at the DP stage of thymic development. First, Foxp3 + DP cells can be found in
TCR transgenic mice in which the T cells encounter their cognate antigen in the thymus
[61, 89]. Second, cTEC-restricted expression of MHC class II is sufficient to induce the
generation of Foxp3+ T cells [55, 56]. Finally, analysis of Foxp3-knockin reporter mice
revealed that Foxp3+ cells can be found in the DP subset [19, 57, 65, 90], which has been
reported to represent precursors to Foxp3+ CD4SP cells [57]. The fraction of total
Foxp3+ thymocytes in the DP stage ranges between ~5 – 30% depending on the gating
scheme and report [57, 65]. Thus, a substantial fraction of Treg cells acquire Foxp3
expression at the DP stage of thymic development.
I reasoned that the TCR repertoire of Foxp3+ DP cells would be different from
that observed for Foxp3+ CD4SP cells [33-35] due to differences in antigen presentation
at these stages of thymic development. However, highly purified populations of Foxp3+
DP cells could not be obtained by flow cytometric sorting.

Here, I show that this

difficulty arises primarily from Foxp3+CD4SP:Foxp3–DP doublets being recognized as
Foxp3+ DP cells. Thus, our data demonstrate that the proportion of Foxp3 + Treg cells in
the DP stage is much lower than previously reported, and argue for a minor role for
Foxp3-induction at the DP stage in the generation of the thymic Treg cell subset.
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Materials and Methods
1. Mice
Foxp3gfp reporter mice was kindly provided by Dr. Alexander Rudensky [65];
MHC class II deficient mice [28] were purchased from the Jackson Laboratory (Bar
Harbor, ME); and B6.SJL CD45.1 congenic mice were purchased from the National
Cancer Institute (Frederick, MD). Mice were analyzed at 6-9 weeks of age, housed in
specific pathogen-free facility at Washington University, and used under protocols
approved by the Animals Studies Committee.

2. Flow cytometry and FACS cell sorting.
Monoclonal antibodies were purchased from eBioscience (San Diego, CA) and
Biolegend (San Diego, CA). Flow cytometric analysis and sorting were performed using
a FACSAria (Becton Dickinson, San Jose, CA) and FlowJo software (Tree Star, Ashland,
OR). For routine flow cytometry, thymocytes were stained at 40x106 /ml in Ca++/Mg++
free DPBS supplemented with 2.5% FCS and 0.02% sodium azide for 20 minutes on ice.
Free antibody was removed by washing after centrifugation. To reduce cell:cell
interaction in certain experiments, I stained in the presence of 1mM EDTA at 4°C with
constant rotation; and instead of washing after centrifugation, the cells were simply
diluted 50 fold in PBS immediately prior to flow cytometry. To assess DNA content,
thymocytes were stained with antibodies under the condition for routine flow cytometry,
and fixed by 0.1% paraformaldehyde in DPBS for at least 2 hours. Fixed thymocytes
were permeablized using 70% ethanol for propidium iodide staining.
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3. Neonatal bone marrow chimera.
Bone marrow cells from Foxp3gfp mice were T-cell depleted using AutoMACS
magnetic bead removal of CD4 and CD8 labeled cells (Miltenyi Biotech, Auburn, CA).
Ten million bone marrow cells were intraperitoneally injected into 2-day old mice.
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Results
Flow cytometric analysis of Foxp3+ DP thymocytes
Previous studies have demonstrated Foxp3+ DP cells in both TCR transgenic and
polyclonal settings [55, 56, 65, 90], with up to ~30% of Foxp3+ thymocytes reported to
be present in the DP subset [57]. I reasoned that Foxp3+ DP and CD4SP cells may
represent Treg cells selected on different arrays of peptide:MHC class II complexes
presented on cortical versus medullary APCs, which could be revealed by a comparison
of the TCR repertoires between DP and CD4SP Foxp3+ cells. However, initial attempts
to purify Foxp3+ DP cells by our usual flow cytometric sorting parameters were
hampered by low purity in the 40-60% range (Figure 3.1).

Even double FACS

purification did not result in a high purity sort (data not shown). This did not appear to
be a mechanical limitation of the sorter, as Foxp3+ CD8SP cells could be sorted with
reasonable purity, even though they are at comparable frequency to Foxp3 + DP cells.
Post-sort analysis of Foxp3+ DP cells showed that a large portion of the
contaminants were Foxp3– DP cells (Figure 3.1). This was expected since Foxp3– DP
cells are by far the most frequent cell-type in the thymus. Surprisingly, many of the
contaminants were Foxp3+ CD4SP cells. Since these cells represent only ~0.3% of total
thymocytes, this suggested that contamination was occurring in a non-random fashion.
Because these contaminants Were present at a 1:1 ratio (Figure 3.1, bottom), this hinted
at the possibility that many of the Foxp3+ DP cells recognized by flow cytometry may
represent doublets of Foxp3– DP and Foxp3+ CD4SP cells.
To test this hypothesis, I performed additional flow cytometric analysis of Foxp3 +
DP cells. An appreciable frequency of Foxp3+ in the DP subset was only observed only
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when generous forward scatter-area (FSC-A) and side scatter-area (SSC-A) gating
parameters were used (Figure 3.2A, large gate). Area parameters are derived from the
integration of height and width parameters (e.g. FSC-H and FSC-W) as the cell passes
through the detector.

However, I found that most Foxp3+ DP cells exhibited an

exaggerated FSC-W compared to FSC-H. The same was true for SSC (data not shown).
This traditionally implies that two cells serially passed the detector so close together that
they could not be discriminated by the cytometer as individual cells. Rather, this event
appears as a single large cell with increased FSC-A/SSC-A due to integration. Consistent
with this interpretation, a smaller FSC/SSC gating scheme (small gate) decreased the
frequency Foxp3+ cells in the DP subset by approximately 20 fold, and eliminated most
of the doublets by FSC-H/FSC-W criteria (Figure 3.2A). Another interesting observation
is that the MFI of CD4 is approximately two-fold greater on Foxp3+ DP cells compared
with Foxp3– DP cells (Figure 3.3A). Taken together, these additional flow cytometric
analyses support the notion that most Foxp3+ DP events are comprised of doublets.
To assess whether doublet formation occurred in vitro during cell-surface labeling
with fluorescent antibodies, I attempted to decrease cell-cell interactions by avoiding
centrifugation and staining in the presence of 1mM EDTA. I found that the frequency of
singlets in the large gate improved considerably, with a corresponding decrease in the
frequency of DP cells in the Foxp3+ subset (Figure 3.3B, Figure 3.5B). Thus, these data
suggest that the majority of doublets observed during routine cell staining and processing
for flow cytometry occur ex vivo.
To confirm the hypothesis that Foxp3+ DP events identified by routine flow
cytometry are comprised of Foxp3– DP cells adhered with Foxp3+ CD4SP cells, I mixed
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CD45.1 Foxp3gfp thymocytes with CD45.2 Foxp3WT thymocytes prior to staining and
flow cytometry. While Foxp3+ CD4SP and Foxp3+ CD8SP cells appropriately expressed
only CD45.1, CD45.2 staining was readily apparent on many Foxp3+ DP events (Figure
3.4A). Assuming that doublet formation was similar between CD45.1 and CD45.2 cells,
this would imply that over 80% of Foxp3+ DP events identified under these conditions
were comprised of doublets generated ex vivo. The efficiency of doublet formation in
vitro was also dependent on cell concentration during staining (Figure 3.5). In addition,
Foxp3+ flow cytometric events with high DNA content were preferentially found in the
DP subset (Figure 3.6). Thus, these data directly demonstrate that doublets are formed ex
vivo and are preferentially found in the Foxp3+ DP gate.
Using this mixing assay to assess doublet formation, I then tested the efficiency of
height by width parameters for “doublet discrimination” gating. I observed that the
frequency of doublets markedly increased as the FSC-H size of the gate increases even if
the FSC-W gating remains unchanged (Figure 3.4B, Figure 3.7).

Furthermore, the

increase in the frequency of Foxp3+ cells in the DP gate (Figure 3.4C) parallels the
frequency of doublets associated with larger FSC-H gates (Figure 3.4B). Conversely, the
frequency of Foxp3+ cells in the CD4SP subset decreases (Figure 3.4C). Thus, while
“doublet discrimination” gating is useful to eliminate doublets which pass through the
detector in series, it can be defeated by a generous FSC-H (and SSC-H) gate, thereby
including doublets which pass through in parallel. Taken together, these data demonstrate
that the frequency of DP cells in the Foxp3+ subset is substantially less than previously
reported [57], representing approximately 1% of Foxp3+ thymocytes (Table 3.1).
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Characterization of Foxp3+ DP thymocytes
As it is unclear whether previous studies excluded doublets from the analysis of
Foxp3+ DP events, I performed a flow cytometric characterization of Foxp3+ DP cells
using a small gate. One observation was that the levels of CD4 and CD8 are lower than
those found on typical Foxp3– DP cells (Figure 3.2, small gate), suggesting that Foxp3+
DP cells Were transitioning out of the DP stage after undergoing positive selection. This
is consistent with the observation that Foxp3+ DP cells are TCRhi and express lower
levels of HSA than Foxp3– DP cells (Figure 3.7). However, the HSA levels on Foxp3+
DP cells were higher than those on Foxp3+ CD4SP cells. In addition, Foxp3+ DP cells
show higher level of CD69 expression than Foxp3– DP, indicating that Foxp3+ DP cells
may have recently received a positively selecting TCR signal. In other respects, DP and
CD4SP cells were similar, expressing Treg surface markers such as CD25, GITR, OX-40
and CD103 (Figure 3.8). Thus, these data suggest that Foxp3+ DP cells have undergone
positive selection and express traditional Treg cell markers.
Since most Foxp3+ thymocytes are presumably MHC class II restricted as most
reside in the CD4SP subset, I asked whether Foxp3+ DP cells require MHC class II for
their development. Consistent with a previous report [65], I observed a marked decrease
in Foxp3+ CD4SP cells and a increase in Foxp3+ DP and CD8SP cells in Foxp3gfp MHC
class II deficient mice (Figure 3.9A). This was also reflected in an overall decrease in
frequency of Foxp3+ thymocytes (Figure 3.9B). Curiously, many Foxp3+ DP cells in
MHC class II-deficient mice in the large gate by FSC-A/SSC-A parameters show
enhanced levels of CD8 compared to their counterpart in wild-type mice. Since these
cells are not present when the small gate is used, they may represent doublets of Foxp3 +
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DP or CD8SP cells with Foxp3– DP cells in MHC class II-deficient mice. Nonetheless,
the presence of Foxp3+ CD4loCD8lo DP cells in MHC class II-deficient mice suggest that
Treg cell selection can occur on MHC class I.

Developmental kinetics of Foxp3+ thymocytes
A previous study of neonatal thymic development showed that Foxp3+ DP and
CD4SP cells appeared coincidently [19]. Since this study examined development in a
neonatal and potentially lymphopenic thymic setting, it was possible that the thymic
medulla was not fully mature [91-93].

I therefore analyzed T cell development in

lymphoreplete thymuses using neonatal bone marrow chimeras. It took approximately
2.5 weeks post transfer of congenically marked bone marrow cells to see appreciable
numbers of developing donor thymocytes (Figure 3.10A). I did not observe a period in
which DP cells contributed a substantial fraction to the total thymic Foxp3 + population
(Figure 3.10B).

Curiously, the frequency of Foxp3+ cells with the CD4SP subset

increased over a period of approximately 1.5 weeks until it reached steady state,
consistent with a delay in Foxp3+ cell development at the CD4SP stage (Figure 3.10C)
observed in neonatal mice [19]. These data therefore illustrate that the temporal delay in
the generation of Foxp3+ as compared with Foxp3– CD4SP cells does not result from
conditions unique to the neonatal thymus.
I also examined the kinetics of Foxp3+ Treg cell development in the CD4SP stage.
Although this time course analysis cannot prove precursor:product relationships, it
appears that Foxp3+ cells arise from the HSAhi CD4SP subset before downregulating
HSA (Figure 3.10D).

Furthermore, Foxp3–CD25+ CD4SP cells, which have been
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suggested to be enriched in thymic Treg cell precursors [52], are found initially at much
higher frequency than Foxp3+ cells, but decrease over time as the frequency of Foxp3 +
correspondingly increases (Figure 3.10E). Although correlative, these data imply that
Treg cell development occurs at the HSAhi CD4SP stage through a Foxp3– CD25+
intermediate.
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Figure Legends
Table 3.1. Summary of CD4/8 distribution of Foxp3+ thymocytes
Data shown are the mean frequency of Foxp3+ thymocytes which fall into the DP,
CD4SP, and CD8SP gates as per Figure 3.2. EDTA indicates whether 1mM EDTA and
avoidance of centrifugation was used to diminish cell:cell interactions. Large and small
gates represent those shown in Figure 3.2.

Figure 3.1. Contaminants in sorted Foxp3+ DP thymocytes
Foxp3+ DP thymocytes were sorted from Foxp3gfp mice and analyzed by flow
cytometry.

Representative plots of two independent experiments are shown. Mean

percentage (± S.D, n=2) of contaminants in sorted cells is derived from the post-sort
gating scheme (%CD4SP x %Foxp3+ and %DP x %Foxp3–).

Figure 3.2. Most Foxp3+ DP events by flow cytometry appear to be doublets.
(A) Flow cytometric analysis of Foxp3+ thymocytes. Thymocytes from Foxp3gfp
mice were stained using our normal protocol and analyzed by flow cytometry. The large
(dotted line) and small (black line) gates use the area parameter, which is integrated
based on the height and width of the signal from an individual event. FSC-H/FSC-W
plots are shown on the right for the indicated Foxp3 + populations. Using these parameters,
a doublet often appears to have a larger width than height, unless the doublet crosses the
beam in tandem. Numbers in the FACS plots represents the frequency of the cells in the
indicated gate. (B) Reduction in Foxp3+ DP events using EDTA and avoidance of
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centrifugation. Thymocytes from Foxp3gfp mouse were prepared as described in the
Methods, and analyzed as above.

Figure 3.3. Most Foxp3+ DP events are composed of doublets.
(A) Foxp3+ DP events are two-fold brighter for CD4 than Foxp3– DP events.
Thymocytes from Foxp3gfp mouse were prepared as described in the Methods, and
analyzed as per Figure 3.2. Mean fluorescence intensity (MFI) of CD4 is shown for
events in the large gate above from 3 independent experiments (± S.D.). (B) Reduction in
Foxp3+ DP events using EDTA and avoidance of centrifugation. Representative flow
cytometric plots analogous to those in Figure 3.2 are shown. (C) Summary of singlet
frequencies in Foxp3+ DP, CD4SP and CD8SP subsets using the large FSC-A/SSC-A
gate above. Each dot represents data from an independent experiment.

Figure 3.4. Doublets in the Foxp3+ DP thymocyte subset
(A) Foxp3+ DP doublets are formed during staining. CD45.2 Foxp3gfp thymocytes
were mixed with CD45.1 Foxp3WT thymocytes at 1:1 ratio, stained using the normal
protocol, and analyzed by flow cytometry using a large FSC-A/SSC-A gate (see Figure
3.2). Data shown are gated on Foxp3gfp+ cells and as indicated above the plots, and a
representative of two independent experiments. The numbers represent the frequency of
the cells in the quadrant. (B) “Doublet discrimination” gating is imperfect for eliminating
doublets. Thymocytes in the large FSC-A/SSC-A gate as in (A) were further analyzed
using gates with small FSC-W and different FSC-H for the frequency of
CD45.1+CD45.2+ doublets. Representative plots and quantification of doublets are shown
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according to FSC-H value. (C) Frequency of Foxp3+ DP cells is proportional to doublet
formation. The mean frequencies of DP and CD4SP in Foxp3+ thymocytes from each
FSC-H gate are plotted.

Figure 3.5. Increased cell concentration during staining enhances the frequency of
Foxp3gfp+ DP events.
Thymocytes were stained as per Figure 3.4 at the indicated cell concentration and
analyzed by flow cytometry. The mean percentages of Foxp3 gfp+ DP cells which are
CD45.1+, and the frequency of Foxp3 gfp+ cells which fall in the DP gate, are shown from
4 independent experiments (± S.D.).

Figure 3.6. Frequency of Foxp3+ DP cells increases with DNA content.
Thymocytes were fixed and stained for DNA content as described in the
Material and Methods section. DNA content was assessed by flow cytometry of PI
staining using a large FSC-A/SSC-A and Foxp3+ gate. Data shown are representative of
2 dependent experiments.

Figure 3.7. Doublet-discrimination gating decreases the frequency of Foxp3 gfp+ DP
events.
Thymocytes were stained as per Figure 3.4 and analyzed by flow cytometry. The
plot on the left was gated using a large FSC-A/SSC-A gate. On the right, the mean
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percentages of CD45.1+CD45.2+ doublets and DP subset in Foxp3gfp+ cells in the
indicated FSC-H/FSC-W gates are shown from 3 independent experiments (± S.D.).

Figure 3.8. Foxp3+ DP and CD4SP cells express similar cell surface markers.
Thymocytes from Foxp3gfp mice were analyzed for cell surface expression of
indicated markers on Foxp3– and Foxp3+ DP cells; and Foxp3– and Foxp3+ CD4SP cells
as indicated using small FSC-A/SSC-A and doublet discrimination (width/height) gates
as per Figure 3.2. Data are representative of 4 mice analyzed.

Figure 3.9. Foxp3+ DP cells can be generated by MHC class I.
(A) Development of Foxp3+ cells in MHC class II-deficient mice.

Foxp3+

thymocytes from wild-type and MHC class II-deficient mice were analyzed using FSCA/SSC-A large (dotted line) and small gates (black line). Plots shown are representative
of three independent experiments. (B) Reduction of Foxp3 + thymocytes generation in the
absence of MHC class II. The mean percentages of Foxp3 + in thymocytes from wild-type
and MHC class II-deficient mice are shown.

Figure 3.10. Kinetics of thymic regulatory T cell development
(A) Delay in generation of Foxp3+ cells in lymphoreplete thymuses. CD45.2
Foxp3gfp T cell-depleted bone marrow cells were intraperitoneally injected into 2-day old
CD45.1 neonates, and donor-derived thymocytes were analyzed by flow cytometry at the
indicated age. Data shown are gated on DP or CD4SP cells, and are representative of
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three independent experiments with at least two mice per time point. (B) Foxp3+ CD4SP
and DP Treg cells are coincidentally observed. Mean percentage of cells in the various
CD4/CD8 subsets amongst the Foxp3+ thymocyte population are plotted. At 2.5 weeks,
too few Foxp3+ events were recorded to allow meaningful comparisons (N/A). (C)
Summary of time course of Foxp3+ cell generation. The frequency of Foxp3+ cells within
the DP or CD4SP subset is plotted with respect to time after bone marrow transfer. Data
shown are mean ±S.D. (n = 3). (D) Appearance of HSAhi Foxp3int cells during the initial
wave of Treg cell development after bone marrow transfer.

Data shown are

representative flow cytometric plots gated on CD45.1–CD45.2+ CD4SP cells.

(E)

Foxp3–CD25+ and Foxp3+ CD4SP cell frequencies are inversely correlated. Data shown
are the mean ± S.D., n=3.
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Large gate

Small gate

EDTA:

–

+

–

+

CD8SP

3.1 ± 0.5

3.2 ± 0.6

4.0 ± 0.1

3.4 ± 0.8

CD4SP

68.8 ± 10

86.8 ± 0.9

87.8 ± 1.5

91.4 ± 1.2

DP

21.5 ± 11

4.1 ± 0.2

1.27 ± 0.4

1.4 ± 0.2

Table 3.1. Summary of CD4/8 distribution of Foxp3+ thymocytes
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Figure 3.1. Contaminants in sorted Foxp3+ DP thymocytes
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Figure 3.2. Most Foxp3+ DP events by flow cytometry appear to be doublets.
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Figure 3.3. Most Foxp3+ DP events are comprised of doublets.
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Figure 3.4. Doublets in the Foxp3+ DP thymocyte subset
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Figure 3.5. Increased cell concentration during staining enhances the frequency of
Foxp3gfp+ DP events.
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Figure 3.6. Frequency of Foxp3+ DP cells increases with DNA content.
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Figure 3.7. Doublet-discrimination gating decreases the frequency of Foxp3 gfp+ DP
events.
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Figure 3.8. Foxp3+ DP and CD4SP cells express similar cell surface markers.
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Figure 3.9. Foxp3+ DP cells can be generated by MHC class I.
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Figure 3.10. Kinetics of thymic regulatory T cell development
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Discussion
These data highlight one circumstance in which identifying rare cell populations
by flow cytometry is problematic due to the congruence of several factors. First, the
gating criteria are based only on positive staining, facilitating the inclusion of doublets.
By contrast, identifying rare Foxp3+ CD8SP cells requires a CD4– gate, excluding
doublets to everything but another CD8SP cell, which is statistically much less likely
assuming random interactions. Second, Foxp3– DP cells represents the vast majority of
thymocytes, making it likely that random doublet formation would include this subset,
regardless of whether there are additional attractive forces between Foxp3+ CD4SP and
Foxp3– DP cells.

Third, the actual Foxp3+ DP cell population appears to be rare,

allowing infrequent doublets of Foxp3+CD4SP with Foxp3–DP to be relatively more
prominent. The low frequency of Foxp3+ DP cells may further encourage staining under
more concentrated cell conditions, facilitating doublet formation (Figure 3.5). Moreover,
the rarity of the cells may prompt more relaxed gating to include as many events as
possible, diminishing the effectiveness of strategies designed to improve “doublet
discrimination” (Figure 3.4 B,C). I believe that relaxed gating resulted in our initial
inability to sort these rare Foxp3+ DP cells with high purity (Figure 3.7). The use of
stringent gating criteria is therefore required for more specific identification of Foxp3+
DP cells.
These data demonstrate that the induction of Foxp3 in the DP stage is a relatively
rare occurrence. Although the use of a small gate may result in the exclusion of larger
Foxp3+ cells which are not doublets, I estimated the frequency of Foxp3+ cells that are
DP cells by flow cytometry to be approximately 1%, which is considerably lower than a
recent estimate [57]. While I cannot exclude that TCR interactions with self-antigens at
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the DP stage condition thymocytes to undergo Treg cell development in a multi-step
process [52], these data suggest that the vast majority of Foxp3 acquisition occurs at the
immature HSAhi stage of CD4SP development (Figure 3.10), and favor a model in which
Treg cell development in the DP and CD4SP stage occur in parallel, rather than in serial
[94].
In addition to the enumeration of Foxp3+ DP cells, these results illustrate the
difficulty of studying with this rare Foxp3+ population. While a difference of 1% versus
3% Foxp3+ cells in the DP gate may be of little importance with regard to the role of Treg
cell development in the DP stage, analysis of a cell population in which the majority was
comprised of doublets would be problematic. For example, TCR sequences from Foxp3 +
DP event would have been difficult to interpret due to contamination with CD4SP Treg
cells. Thus, great care should be taken with functional, developmental, or phenotypic
evaluation of Foxp3+ DP cells to avoid the potential for bias by inclusion of Foxp3 +
CD4SP cells due to doublets.
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Chapter 4
Concluding Remarks and Future Directions

As Foxp3+ CD4+ Treg cells plays an important role in the maintenance of
tolerance to self, studying the development of Treg cells is essential to understand
tolerance mechanism required to prevent autoimmunity. I have studied differentiation of
thymic Treg cells using TCR repertoire analysis by addressing two questions. How does
self-reactivity of TCR drive Treg cell development? (Chapter 2) When does
differentiation of Treg cells occur in the thymus? (Chapter 3) In my dissertation study, I
showed that differentiation of thymic Treg cells is instructed by TCR reactivity for selfantigen presented by mTEC, thereby most of Treg cells appear at immature CD4SP stage.
Moreover, assessment of the effect of TCR affinity in negative selection and peripheral T
cell response gave an insight of how self-reactivity of TCR operates to establish self
tolerance and to prevent autoimmunity.

How much self-reactivity is required for thymic Treg cell development?
Although the notion that self-reactivity plays a critical role in thymic Treg cell
development has been supported by many reports for a decade, the degree of T cell selfreactivity considered dangerous by the immune system, thereby requiring thymic
education to prevent autoimmunity, is unknown. I analyzed a panel of TCRs with a broad
range of reactivity to ovalbumin (OVA323-339) in the RIP-mOVA self-antigen model for
their ability to induce mechanisms of thymic tolerance. In Chapter 3, I quantified TCR
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specificity and correlated it with thymic T cell selection, such as Treg development and
negative selection. Thymic Treg cell generation in vivo was directly correlated with
reactivity to OVA-peptide in a broad ~1,000-fold range, and its developmental “niche
size” was unexpectedly dependent on TCR affinity.

The threshold for Treg cell

differentiation was almost 100-fold lower than that required for eliciting thymic negative
selection and peripheral T cell responses. Thus, these data suggest that Treg cell
differentiation is a default outcome of self-antigen encounter for CD4+ thymocytes, and
that thymic tolerance mechanisms are tuned to limit the escape of self-reactive effectors
without Treg cell chaperones into the periphery.

Timing of Treg cell development in the thymus
The CD4+CD8+ (DP) stage of thymic development has been thought to be the
earliest period which generates natural Treg cells important for the prevention of
autoimmunity. However, I found that most Foxp3+ DP cells identified by routine flow
cytometry represent doublets comprised of Foxp3 – DP and Foxp3+ CD4+CD8– (CD4SP)
cells.

This was determined using analysis of flow cytometric height and width

parameters, post-sort contaminants, and thymocyte mixing studies. Temporal analysis of
Treg cell development arising from bone marrow precursors in neonatal bone marrow
chimeras suggested that Foxp3+ DP cells are not a major percentage of Foxp3+
thymocytes, and supported the notion that most Treg cell development occurred at the
immature HSAhi CD4SP stage.

Thus, these data demonstrate that the frequency of

Foxp3+ cells generated at the DP stage is much smaller than previously recognized,
suggesting that additional thymocyte maturation may be required to facilitate efficient
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induction of Foxp3. In addition, this study highlights a potential bias which may happen
in identifying very rare population among DP cells comprising most of thymocytes.

Questions to be addressed
Observations from my dissertation study, lead to interesting questions regarding
the role of TCR affinity in mechanisms of establishing tolerance to self in the thymus and
periphery. Does thymic Treg cell differentiation utilize continuous signaling mode or
digital threshold mode? Does interclonal competition inhibit Treg cell development of
lower affinity TCRs? How does TCR affinity affect effector versus Treg cell generation
in the periphery? Does the level of self-reactivity control suppressor function of Treg
cells? A panel of OVA-reactive TCRs obtained in this dissertation would be useful to
address these questions.

TCR signaling mode for thymic Treg cell development
It was demonstrated that Treg cell differentiation is driven by self-reactivity to
likely non-ubiquitous tissue-specific antigen, and that this is reflected in the size of the
Treg cell developmental niche in my dissertation study. This leads to an important
question. How is the level of TCR-antigen interaction translated into Foxp3 expression?
This may be explained in two different models. One model is that there is a TCR
stimulation threshold required for Foxp3 induction. Another model is that the level of
TCR stimulation translated into the degree of Foxp3 expression in continuous manner, by
which strong TCR stimulation increases the probability of Foxp3 induction. The
approach to address this question would be using the panel of OVA-reactive TCRs to
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examine whether TCR signals are interpreted in a digital or analog manner for Foxp3
expression. To evaluate the strength of TCR signaling in vivo, we obtained a new
reporter mouse, Nur77-GFP [43] from Dr. Hogquist (U of Minnesota), and are breeding it
to Rag1–/– in B6.C background to obtain donor DN thymocytes for retroviral bone
marrow chimera or intrathymic transfer.
If Treg cell development occurs in digital threshold model, it would be expected
to be observed that Treg cells will always show a certain level of GFP irrespective of
TCR affinity, in which lower affinity TCRs results in less number of cells with the same
GFP level, while the level of effector T cells would vary with TCR affinity. On the other
hand, if Treg cell differentiation is based on continuous TCR signaling, the level of GFP
in Treg cells would differ depending on TCR affinity, where intensity of GFP from Treg
cells decreases with lower TCR affinity. Since c-Rel has been reported to play a primary
role in Treg cell development by interpreting TCR stimulation into Foxp3 expression [9598], it would be worth to examine whether NF-κB pathway is activated in digital manner.

Interclonal competition in thymic Treg cell development
Although it was shown that the size of Treg cell development niche is dependent
on TCR affinity to self-antigen, it remains unclear how thymocytes with various affinity
interact with the limited niche. Thus, it would be interesting to examine whether there is
interclonal competition among self-reactive thymocytes for the same self-antigen, and
whether it inhibits Treg cell differentiation of thymocytes with lower self-reactivity. The
panel of OVA-reactive TCRs would be useful tool to test the hypothesis that interclonal
competition may favor the differentiation of Treg cells of higher self-reactivity, while
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cells with lower self-reactivity develop as effector cells. If interclonal competition is
observed, it would suggest that TCRs with lower affinity for self-antigen is more likely to
escape thymic tolerance mechanism as effector cells, potentially autoimmune T cells,
whereas self-reactive TCRs have higher probabilities of undergoing thymic education to
preserve tolerance.
To test whether high affinity TCR would affect Treg cell development of the
other TCR, a TCR in the panel (e.g. N7) would be transferred with DO11, the highest
affinity TCR in, into the of congenic hosts. One expected outcome from this experiment
is that DO11 has no effect on development of the second TCR into Treg cells, suggesting
that niche size is sufficient for Treg cell differentiation of both TCRs. This may suggest
that Treg cell development occurs independently in terms of self-reactivity of thymocyte
population. On the other hand, Treg cell differentiation may be hindered by higher
affinity TCRs. This may imply that lower affinity TCRs are outcompeted by higher
affinity, resulting in escape of thymocytes with lower affinity from thymic tolerance
mechanism, becoming effector T cell subset.

Interclonal competition for peripheral antigenic niche
The degree of self-reactivity of TCR was demonstrated to play an instructive role
in thymic Treg cell generation in this study. Self-reactivity is also known to drive
peripheral autoimmune responses [85, 99]. However, the relationship of self-reactivity
between thymic and peripheral tolerance is unknown. Moreover, the level of selfreactivity inducing peripheral Treg cell generation compared to that of autoimmune
effector cells is unknown. Thus, it would be interesting to see how TCRs with varying
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affinities compete for the same peripheral antigenic niche, and whether high affinity
TCRs outcompete low affinity ones in competition peripheral self-antigen, resulting that
the antigen specific Treg cell pool is mostly filled with Treg cells with high affinity TCRs.
The panel of OVA-reactive TCRs will be used to study the quantitative role of selfreactivity in peripheral tolerance as well. Peripheral CD4 T cells expressing individual
OVA-reactive TCR will be transferred into RIP-mOVA hosts and assessed for Treg
versus effector T cell development by flow cytometry. One possible outcome is that selfreactivity of TCR will be correlated with peripheral generation of Treg cell. By contrast,
TCR affinity may not contribute much to Treg cell generation unlikely its instructive role
in the thymus. This would suggest that other factors besides TCR affinity control cell fate
into Treg cells in the periphery.

Role of TCR affinity for Treg cell suppression of autoimmunity
Given that Treg cells need TCR stimulation to exert their suppressive function, it
is unknown whether Treg cells recognize same self-antigen as effector T cells to protect
autoimmunity. Moreover, it has not been studied which level of self-reactivity in the Treg
cells is required to suppress autoimmune effector T cells. These questions would be
directly addressed using OVA-reactive TCRs generating Treg cells with varying affinities.
Initially, naïve T cells will be sorted and transferred into RIP-mOVA Rag1-/- hosts to
determine the level of TCR affinity required to induce autoimmune diabetes. After
establishing conditions for diabetes induction in RIP-mOVA Rag1-/- mice, Treg cells
expressing individual TCR will be co-transferred with naïve T cells to determine the level
of self-reactivity of Treg cells to prevent or mitigate diabetes. Results from this study
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could address a question whether Treg cells need to have a higher or equal affinity to
peripheral self-antigen for efficient suppression of effector T cells.
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